FUNGICIDAL OXAZOLIDINONES

Abstract: This invention pertains to novel compounds of formula (I) including all geometric and stereoisomers, agricultural compositions containing them and their use as fungicides wherein W is O, S or N-Q-R<58>, and R<1>, R<2>, R<3>, and R<4> are various groups.

Description: UL InZ FϋNGICIDAL OXAZOLIDINONES * FIELD OF THE INVENTION i 5 The present invention relates to substituted 6 oxazolidinone compounds, fungicidal compositions containing such compounds, and method of use of the compounds and compositions as fungicides. BACKGROUND OF THE INVENTION 10 New compounds effective for controlling the growth of undesired fungi are in constant demand. In the most common situation, such compounds are sought to selectively control the growth of fungi in useful crops such as cotton, rice, corn, wheat and soybeans, to name 15 a few. Unchecked fungus growth in such crops can cause significant losses, reducing profit to the farmer and increasing costs to the consumer. There are many products commercially available for these purposes, but the need continues for products which are more 20 effective, less costly and environmentally safe. WO90/12791 teaches the use of fungicidal compounds of Formula i 25 i wherein: A is 0 or NR 4 ; and W is 0 or S. ■ . WO90/12791 also relates to processes for the 30 preparation of these compounds and to certain novel compounds. The compounds of O90/12791 differ from those of the present invention in the nature of R 2 . The above reference does not disclose the compounds of the present invention. The compounds of the prior art, although useful as fungicides, tend to have drawbacks including poor efficacy, toxicity to non-target organisms and/or unacceptable environmental effects. A need therefore exists for fungicidal products and methods of application which address the limitations of the prior art. SUMMARY OF THE INVENTION The present invention comprises compounds of Formula I including all geometric and stereoisomers, agricultural compositions containing them and use of the compounds and compositions as fungicides. The variation in Formula I occurs primarily in substituent R 2 . Formula I comprises: wherein: R 1 is H; C-.-C 4 alkyl; C^^ haloalkyl; C 3 -C 6 cycloalkyl; C 2 -C alkenyl; C 2 -C 4 alkoxycarbonyl; or phenylmethyl optionally substituted on the phenyl ring with R 6 and on the benzylic carbon with R 7 ; R 2 is C7-C 20 alkyl; C 7 -C 2 o haloalkyl; C 4 -C 17 alkyl substituted with C 3 -C 6 cycloalkyl; C 4 -C 17 alkyl substituted with phenyl optionally substituted with R 31 on the phenyl ring; C 3 -C 14 alkyl substituted with phenoxy or phenylthio each optionally substituted with R 31 ; C 1 -C o alkyl substituted with R 19 ; C 2 -C 6 alkoxyalkyl substituted with R 21 ; C 7 -C 2 o alkoxyalkyl optionally substituted with R 21 ; C 7 -C 20 alkenyl; C 2 -C 20 alkenyl substituted with R 20 ; C 7 -C 20 alkynyl; C 2 -C 20 alkynyl substituted with R 48 ; C 5 -C 7 cycloalkenyl; (CH 2 CH 2 OCH 2 CH 2 )CH-; (CH 2 CH 2 N(R 15 )CH 2 CH 2 )CH-; (CH 2 CH 2 SCH 2 CH 2 )CH-; (CH 2 CH 2 S0 2 CH 2 CH 2 )CH-; pyrimidyl, pyrazinyl, pyridazinyl, oxazolyl, isoxazolyl, isothiazolyl or thiazolyl each optionally substituted with R 26 and R 18 ; furanyl substituted with one substituent selected from R 26 and one from R 18 ; pyridyl substituted with one substituent selected from R 49 , or one group from R 50 and one from R 18 ; or -T-Z; R 3 is phenyl, pyridyl, pyrimidinyl or pyridazyl each optionally substituted with R 10 ; or phen l ethy1; R 4 is H, methyl, or aσetyl; R 5 , R 7 , R 11 , R 14 , R 23 , R 24 , R °, R 39 , R 43 , and R 55 are each independently H or C 1 -C 4 alkyl; R 6 , R 29 , R 34 , R 38 , R 42 , R 44 , and R 56 are each independently 1-2 halogen; Cι~C 4 alkyl; C 1 -C 4 alkoxy; trifluoromethyl; methylthio; or nitro; R 8 is C- L -Cig alkyl; C 2 -C 19 alkylcarbonyl; C 2 -C 19 alkoxycarbonyl; (R 9 R 14 N)C=0; phenyl optionally substituted with R 27 ; or phenoxycarbonyl optionally substituted with R 17 ; R 9 is C 1 -C 18 alkyl; or phenyl optionally substituted with R 17 ; R 10 , R 27 , and R 45 are each independently 1-2 substituents selected from the group consisting of trifluoromethyl, trifluoromethoxy, nitro, C0 CH 3 , halogen, C 1 -C alkyl, C-^-^ alkoxy, and cyano; R 12 is H; C j -Cs alkyl optionally substituted with C 2 -C 7 alkoxycarbonyl; C 3 -C 8 alkenyl; phenylmethyl optionally substituted on the phenyl ring with R 34 and on the benzylic carbon with R 5 ; phenyl optionally substituted with R 34 ; or pyridyl optionally substituted with R 34 ; or R 11 and R 58 can be taken together as -CH 2 (CH 2 ) 2 CH 2 - —CH 2 (CH 2 ) 3 CH 2 —, —CH 2 (CH 2 ) CH —, —CH 2 CH 2 OCH 2 CH 2 —, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 N(R 5 )CH 2 CH 2 - or -CH 2 CH 2 N(R 5 )CH 2 CH 2 CH 2 - along with the nitrogen to which they are attached to form a ring; R 13 is C^-Cg alkyl; C 3 -C 6 cycloalkyl; phenyl optionally substituted with R 45 ; or phenylmethyl optionally substituted on the phenyl ring with R 34 and on the benzylic carbon with R 5 ; R 15 is C 1 -C 12 alkyl; C -C 12 alkylcarbonyl; benzoyl optionally substituted with R 16 on the phenyl ring; C 2 -C 12 alkox carbonyl; C 2 -C 12 alkylamino- carbonyl substituted with R 55 on nitrogen; phenoxycarbonyl optionally substituted with R 46 on the phenyl ring; or phenylaminocarbonyl optionally substituted with R 46 on the phenyl ring and with R 55 on nitrogen; R 16 is 3 halogen; cyano; C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; C 1 -C 8 haloalkoxy; c l -c 8 alkylsulfonyl; C 2 -C 8 alkoxyalkyl; C 2 -C 8 alkoxyalkoxy; C 2 -C 8 alkylthio; C 2 -C 8 alkenyl; C 2 -C 8 haloalkenyl; C 2 -C 8 alkynyl; hydroxycarbonyl; C 2 -C 8 alkoxy-carbonyl; or phenoxy substituted with R 29 ; R 17 , R 18 , R 32 , R 35 , R 47 , and R 53 are each independently 1-2 halogen; C 1 -C 2 alkyl; trifluoromethyl; or C 1 -C 2 alkoxy; R 19 is cyano; nitro; C -C^ alkylthio; C-,-C 19 alkylsulfinyl; C 1 -C 19 haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 19 alkenyloxy; C 3 -C 19 alkynyloxy; C^C^ alkylsulfonyl; C 2 -C 19 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC (=0) 0; R 8 R 3 N; (C- 2 -C- 4 alkoxy) 2 P (=E)0; R 33 S0 3 ; R 43 R 1 R 23 N+; phenylsulfonyl, phenyl-sulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranyloxy; or C(=J)R 24 ; R 20 is cyano; nitro; alkylsulfinyl; C-^-C- ^ - j haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 3 -C 17 haloalkynyl; C 3 -C 17 alkynyloxy; C 1 -C 17 alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 0C(=0)0; R 22 R 43 NC(=0)0; R 8 R 43 N; (C^^ alkoxy) -P (=E)0; R 33 S0 3 ; R 43 R 14 R 23 N+; phenyl-sulfonyl, phenylsulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranyloxy; C-i-^-. ? alkoxy; 1-3 halogen; C 2 -C 17 alkoxy- alkoxy; C 3 -C 17 alkynyl; C 3 -C 6 cycloalkyl; or phenyl or phenoxy each optionally substituted with R 31 ; R 21 is cyano; nitro; C 1 -C 17 alkylthio; C 1 -C 17 alkylsulfinyl; haloalkoxy; C 5 -C 6 cycloalkyloxy; C 2 -C 17 haloalkenyl; C 3 -C 17 alkenyloxy; C 3 -C 17 haloalkynyl; C 3 -C 17 • alkynyloxy; C 1 -C 17 alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 0C(=0)0; R 22 R 43 NC (=0)0; R 8 R 43 N; (C^-C- alkoxy) 2 P (=E)0; R 33 S0 3 ; R 3 R 1 R 23 N+; phenylsulfonyl, phenylsulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl r naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyran loxy; C^-C^ alkoxy; C 2 -C 17 alkoxyalkoxy; C 3 -C 17 alkynyl; C 3 -C 6 cycloalkyl; phenyl or phenoxy each optionally substituted with R 31 ; or C 2 -C 17 haloalkoxyalkoxy; R 22 is Ci-C^g alkyl; phenyl optionally substituted with R 36 ; or pyridyl optionally substituted with R 36 ; R 25 is H; C^Cg alkyl; or phenyl optionally substituted with R 35 ; R 26 is C j^ -Cg alkyl; i-Cg alkoxy; phenoxy substituted with R 53 , or benzyloxy substituted on the phenyl ring with R 53 ; R 28 is phenyl, pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, isoxazolyl, oxazolyl or pyrazolyl each optionally substituted with R 38 ; R 31 , R 36 , R 37 , R 41 , R 46 are independently 1-2 substituents selected from the group consisting of trifluoromethyl, trifluoromethoxy, nitro, C0 2 CH 3 , halogen, C 1 -C alkyl, C^C, } alkoxy, and cyano; or phenoxy substituted with R 44 ; R 33 is Ci-C alkyl; or phenyl optionally substituted with R 32 ; R 40 is pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, pyrazolyl, naphthalenyl, isothiazolyl, thiazolyl, imidazolyl, oxazolyl, or isoxazolyl each optionally substituted with R 38 ; 2-tetra- hydropyranyl; or 2-tetrahydrofuranyl; R 48 is cyano; nitro; ^-C^ alkylthio; C^C^ alkylsulfinyl; C ] _-C 17 haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 3 -C 17 alkynyloxy; C^C^ alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 3 NC (=0)0; R 8 R 3 N; (C-,-C 4 alkoxy) 2 P (=E)0; R 33 S0 3 ; R 43 R 14 R 23 N+; phenylsulfonyl, phenylsulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranyloxy; C 1 -C 17 alkoxy; 1-3 halogen; C 2 -C 17 alkoxyalkoxy; C 3 -C 6 cycloalkyl; or phenyl or phenoxy each optionally substituted with R 31 ; R 49 is C 5 -C 12 alkyl; C 2 -C 12 haloalkyl; C 5 -C 12 alkoxy; C 1 -C 12 haloalkoxy; C 2 -C 12 alkylthio; C 1 -C 12 haloalkylthio; C 2 -C 1 alkenyl; C 2 -C 1 haloalkenyl; C 3 -C 12 alkynyl; C 2 -C 12 haloalkynyl; C 3 -C 1 alkenyloxy; C 3 -C 12 haloalkenyloxy; C 3 -C 12 alkynyloxy; C -C 12 alkylsulfonyl; C 1 -C 12 haloalkylsulfonyl; C 2 -C 12 alkoxyalkyl; C 2 -C 12 alkoxyalkoxy; C 2 -C 12 .alkoxycarbonyl; N(CH 3 ) 2 ; or G; R 50 is C;,-Cg alkyl; C-i-Cg haloalkyl; C j^ -C alkoxy; C j^ -Cg haloalkoxy; C^C alkylthio; Ci-C haloalkylthio; C 2 -C 6 alkenyl; C 2 -C 6 haloalkenyl; C 3 -C 6 alkynyl; C 2 -C 6 haloalkynyl; C 3 -C 6 alkenyloxy; C 3 -Cg haloalkenyloxy; C 3 -C 6 alkynyloxy; C 3 -Cg cycloalkyl; C 3 -Cg cyclo¬ alkyloxy; C^Cg alkylsulfonyl; C^C halo- alkylsulfonyl; C 2 -C 6 alkoxyalkyl; C 2 -Cg alkoxy¬ alkoxy; C 2 -Cg alkoxycarbonyl; N(CH 3 ) 2 ; or Y; R 51 is phenyl substituted with R 52 ; pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, isoxazolyl, oxazolyl, or pyrazolyl each optionally substituted with R 38 ; R 52 is 3 halogen; cyano; C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; C-L-C 8 haloalkoxy; C 1 -C 8 alkylsulfonyl; C -C 8 alkoxyalkyl; C 2 -C 8 alkoxyalkoxy; C 2 -C 8 alkylthio; C 5 -C 6 cyclo¬ alkyl; C 5 -C 6 cycloalkyloxy; C 2 -C 8 alkenyl; C 2 -C 8 haloalkenyl; C -C 8 alkynyl; hydroxy¬ carbonyl; C 2 -C 8 alkoxycarbonyl; or phenoxy optionally substituted with R 29 ; R 54 is phenyl substituted with R 37 ; pyridyl or pyrimidyl each optionally substituted with R 37 7 or thienyl, furanyl, isoxazolyl, -oxazolyl, or pyrazolyl each optionally substituted with R 38 ; R 57 is C 1 -C 12 alkyl; C 3 -C 6 cycloalkyl; C 1 -C 12 haloalkyl; C 3 -C 12 alkenyl; C 3 -C 12 haloalkenyl; C 3 -C 12 alkynyl; C 3 -C 12 haloalkynyl; phenyl, naphthalenyl or pyridyl each optionally substituted with R 41 ; or furanyl or thienyl each optionally substituted with R 42 ; R 58 is R 12 , C(=0)R 13 , C(=0)OR 13 or C(=0)NR 13 R 30 ; R 59 is phenyl optionally substituted with R 38 ; A is 0, NR 25 , or a direct bond; E and V are independently 0 or S; G is- -OR 51 ; -SR 51 ; -NHR 28 ; -N(CH 3 )R 28 ; -CH=CHR 28 (cis or trans); -C(=V)OR 28 ; -OC(=V)R 28 ; R 28 NR 39 C(=V)0-; -OC(=V)OR 28 ; -C(=V)NR 39 R 28 ; -(CH 2 ) m OR 59 ; -0(CH 2 ) m R 59 ; -(CH 2 ) m R 59 ; or phenyl optionally substituted with R 38 ; J is 0 or N-A-L; L is H; C x -C 8 alkyl, C 3 -C 8 alkenyl; phenylmethyl optionally substituted with R 47 on the phenyl ring and R 55 on the benzylic carbon; phenyl optionally substituted with R 47 ; pyridyl optionally substituted with R 47 ; C(=0)R 22 ; C(=0)OR 22 ; or C(=0)NR 22 R 7 ; m is 1-4; n is 3-4; Q is 0, NR 11 , or a direct bond; T is phenyl optionally substituted with 1-2 halogen; C ; t-C 4 alkyl; C 1 -C 4 alkoxy; trifluoro¬ methyl; methylthio; or nitro; W is 0, S, or N-Q-R 58 ; Y is -OR 28 ; -SR 28 ; -NHR 28 ; -N(CH 3 )R 28 ; -CH=CHR 28 (cis or trans); -C(=V)OR 28 ; -OC(=V)R 28 ; R 28 NR 39 C (=v)θ-; -OC(=V)OR 28 ; -C(=V)NR 39 R 28 ; -(CH 2 ) m OR 59 ; -0(CH 2 ) m R 59 ; -(CH 2 ) m R 59 ; or phenyl . optionally substituted with R 38 ; and Z is phenoxy substituted with R 16 ; C 3 -C 12 alkoxy- alkoxyalkoxy; benzyloxymethoxy optionally substituted on the phenyl ring with R 56 ; C 5 -C 6 cycloalkyloxy; styryl optionally substituted on the phenyl ring with R 41 ; -C(=V)0R 57 ; -OC(=V)R 57 ; -OC(=V)NR 39 R 57 ; -0C(=V)0R 57 ; -C(=V)NR 39 R 57 ; -(CH 2 ) n R 59 ; -(CH 2 ) n 0R 59 ; , -0(CH 2 ) n R 59 ; or -OR 40 ; and the agriculturally suitable salts thereof; provided that: i) when is N-Q-R 58 , Z is other than phenoxy substituted with R 16 , C 5 -C 6 cycloalkyloxy, or -C(=0) (Ci-Cs alkoxy); ii) when R 2 is an optionally substituted phenyl or heterocyclic ring, only H or F can be substituted on the carbon atom(s) of the phenyl or heterocyclic ring adjacent to the carbon bearing the oxazolidinone ring; iii) when two substituents are selected from the alkyl and alkoxy groups in R 10 , R 27 , R 31 , R 36 , R 37 , R 41 , R 45 or R 46 , then at least one of said substituents contains only one carbon atom; and iv) when R 2 is alkyl substituted with optionally substituted phenyl, then the phenyl group is not attached to the alkyl carbon attached to the oxazolidinone ring. This invention further comprises a fungicidal composition comprising an effective amount of a compound of Formula I as defined above and at least one of (a) a surfactant, (b) an organic solvent, and (c) at least one solid or liquid diluent. The invention further comprises a method of controlling fungal diseases in plants, comprising treating the locus to be protected with an effective amount of a compound of Formula I, as defined above.- The preferred compounds for use in the method of the present invention are defined as below for the compounds of the invention. DETAILED DESCRIPTION OF THE INVENTION In the above recitations, the term "alkyl", used either alone or in compound words such as "alkylthio" or "haloalkyl" denotes straight chain or branched alkyl; e.g., methyl, ethyl, π-propyl, i-propyl, or the different butyl, pentyl, hexyl, etc. isomers. The designation "Me" denotes methyl. "Cycloalkyl" denotes cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. The term "cycloalkyloxy" denotes the same groups linked through an oxygen atom such as cyclopentyloxy and cyclohexyloxy. "Cycloalkenyl" denotes groups such as cyclopentenyl, cyclohexenyl, and cycloheptenyl. "Alkenyl" denotes straight chain or branched alkenes; e.g., 1-propenyl, 2-propenyl, 3-propenyl and the different butenyl , pentenyl, hexenyl, etc. isomers . Alkenyl also denotes polyenes such as 1, 3-hexadiene and 2, , 6-heptatriene. "Alkynyl" denotes straight chain or branched alkynes; e.g., ethynyl, 1-propynyl, 3-propynyl and the different butynyl, pentynyl, hexynyl, etc. isomers. "Alkynyl" can also denote moieties comprised of multiple triple bonds; e.g., 2, 7-octadiyne and 2,5, 8-decatriyne. "Alkoxy" denotes methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy, pentoxy, hexyloxy, etc. isomers. Examples of "alkoxyalkoxyalkoxy" include CH 3 OCH 2 CH 2 OCH 2 0, CH 3 CH 2 OCH 2 CH 2 OCH 2 0, and (CH 3 ) 2 CH0CH 2 CH 2 0CH 2 0. "Alkenyloxy" denotes straight chain or branched alkenyloxy moieties. Examples of alkenyloxy include H 2 C=CHCH 2 0, (CH 3 ) 2 C=CHCH 2 0, (CH 3 )CH=CHCH 2 0, (CH 3 )CH=C(CH 3 )CH 2 0 and CH 2 =CHCH 2 CH 2 0. "Alkynyloxy" denotes straight or branched alkynyloxy moieties . Examples include HC≡CCH 2 0, CH 3 C≡CCH 2 0 and CH 3 C≡CCH 2 CH 2 0. "Alkylthio" denotes methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and hexylthio isomers. "Alkylsulfinyl" denotes both enantiomers of an alkylsulfinyl group. For example, CH 3 SO, CH 3 CH 2 SO, CH 3 CH 2 CH 2 SO, (CH 3 ) 2 CHSO and the different butyl- sulfinyl, pentylsulfinyl and hexylsufinyl isomers. Examples of "alkylsulfonyl" include CH 3 S0 , CH 3 CH 2 S0 2 , CH 3 CH 2 CH 2 S0 2 , (CH 3 ) 2 CHS0 2 and the different butylsulfonyl, pentylsulfonyl and hexylsulfonyl isomers. The term "halogen", either alone or in compound words such as "haloalkyl", denotes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as "haloalkyl", said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of "haloalkyl" include F 3 C r C1CH 2 , CF 3 CH 2 and CF 3 CF 2 . Examples of "haloalkenyl" include (C1) 2 C=CHCH 2 and CF 3 CH 2 CH=CHCH 2 . Examples of "haloalkynyl" include HC≡CCHCl, CF 3 C≡C, CC1 3 C≡C and FCH 2 C≡CCH 2 . Examples of "haloalkoxy" include CF 3 0, CC1 3 CH 2 0, CF 2 HCH 2 CH 2 0 and CF 3 CH 2 0. Examples of "haloalkylthio" include CC 3 S, CF 3 S, CC1 3 CH 2 S and CH 2 C1CH 2 CH 2 S. Examples of "haloalkyl¬ sulfonyl" include CF 3 S0 2 , CC1 3 S0 2 , CF 3 CH 2 S0 2 and CF 3 CF 2 S0 2 . Examples of "haloalkoxyalkoxy" include CF 3 0CH 2 0 r C1CH 2 CH 2 0CH 2 CH 2 0, C1 3 CCH 2 0CH 2 0 as well as branched alkyl derivatives . The total number of carbon atoms in a substituent group is indicated by the "C-L-C-J" prefix where i and j are numbers from 1 to 20. For example, C1-C 3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl; C 2 alkoxyalkoxy designates CH 3 0CH 2 0; C 3 alkoxyalkoxy designates, for example, CH 3 OCH CH 0 or CH 3 CH 2 0CH 2 0; and C alkoxyalkoxy designates the various isomers of an alkoxy group substituted with a second alkoxy group containing a total of 4 carbon atoms, examples including CH 3 CH 2 CH 2 OCH 2 0, and CH 3 CH 2 OCH 2 CH 2 0. Examples of "alkoxyalkyl" include CH 3 OCH 2 , CH 3 OCH 2 CH 2 , CH 3 CH 2 OCH 2 , CH 3 CH 2 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 . Examples of "alkoxycarbonyl" include CH 3 OC(=0), CH 3 CH 2 OC(=0) , CH 3 CH 2 CH 2 OC(=0) , (CH 3 ) 2 CH0C(=0) and the different butoxy-, pentoxy- and hexyloxycarbonyl isomers. In the above recitations, when a compound of Formula I is comprised of one or more pyridyl, pyrimidinyl, pyridazyl, pyrazinyl, oxazolinyl, isoxazolinyl, isothiazolyl, or thiazolyl rings, all bonds to these heterocycles are made through the carbon atom(s) of the heterocyclic ring. Preferred for greatest fungicidal activity and/or ease of synthesis are the compounds of Preferred 1 that are the compounds of Formula I wherein: Preferred 1 : R 1 is H; C 1 -C 2 alkyl; or vinyl; R 2 is C 7 -C 20 alkyl; C7~C 20 haloalkyl; C 3 -C 8 alkyl substituted with phenoxy or phenylthio each optionally substituted with R 31 ; C^C^ alkyl substituted with R 19 ; C 2 -C 6 alkoxyalkyl substituted with R 21 ; C 7 -C 16 alkoxyalkyl optionally substituted with R 21 ; C 7 -C 20 alkenyl; C 2 -C 16 alkenyl substituted with R 20 ; pyridyl substituted with one substituent selected from R 49 , or one group from R 50 and one from R 18 ; or -T-Z; R 3 is phenyl optionally substituted with C 1 -C 2 alkyl or halogen; R 4 is H or methyl; R 12 is C^-C^ alkyl; phenylmethyl; or phenyl; R 19 is C j^ -C j^ g alkylthio; C^C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 19 alkenyloxy; C^C^ alkylsulfonyl; C 2 -C 19 alkoxycarbonyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC (=0)0; phenylsulfonyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl or furanyl each optionally substituted with R 38 ; 2-tetrahydropyranyloxy; or CH(=N-A-L); R 20 is C- L -C- L -; alkylthio; C^C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 1 -C 17 alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC (=0)O; R 22 R 43 NC (=0)0; phenylsulfonyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl or furanyl optionally substituted with R 38 ; 2-tetrahydropyranyloxy; C 1 -C 17 alkoxy; 1-3 halogen; C 3 -C 6 cycloalkyl; or phenyl or phenoxy each optionally substituted with R 31 ; R 21 is C 1 -C 17 alkylthio; C^-C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 1 -C 17 alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxy¬ carbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 3 NC (=0)0; phenylsulfonyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl or furanyl each optionally substituted with R 38 ; 2-tetrahydropyranyloxy; C 1 -C 17 alkoxy; C 2 -C 17 alkoxyalkoxy; or phenyl or phenoxy each optionally substituted with R 31 ; R 28 is phenyl or pyridyl each optionally substituted with R 37 ; or thienyl or furanyl each optionally substituted with R 38 ; R 40 is pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl or furanyl each optionally substituted with R 38 ; 2-tetrahydro- pyran l; or 2-tetrahydrofuranyl; R 51 is phenyl substituted with R 52 ; pyridyl optionally substituted with R 37 ; or thienyl or furanyl each optionally substituted with R 38 ; R 57 is C 1 -C 12 alkyl; C 3 -C 6 cycloalkyl; C 1 -C 12 haloalkyl; phenyl, naphthalenyl or pyridyl each optionally substituted with R 41 ; or furanyl or thienyl each optionally substituted with R 42 ; R 58 is R 12 ; A is O or NR 25 ; G is -OR 51 or -SR 51 ; L is H; C x -C 8 alkyl; phenylmethyl optionally substituted with R 47 on the phenyl ring; phenyl optionally substituted with R 47 ; or C(=0)R 22 ; Q is OH, NH, or a direct bond; Y is -OR 28 or -SR 28 ; and Z is phenoxy substituted with R 16 ; -C(=0)OR 57 ; -OC(=0)R 57 ; -OR 40 ; or -OC (=0)NHR 57 . provided that the total number of carbons in R 2 is less than or equal to 20; More preferred are the compounds of Preferred 2 that are the compounds of Preferred 1 wherein: Preferred 2 : R 1 is methyl; R 2 is C 7 -C 20 alkyl; C 7 -C 20 haloalkyl; C 3 -C 8 alkyl substituted with phenoxy or phenylthio each optionally substituted with R 31 ; C^C-^ alkyl substituted with R 19 ; C 2 -C 6 alkoxyalkyl substituted with R 21 ; C 7 -C 16 alkoxyalkyl optionally substituted with R 21 ; C 7 -C 20 alkenyl; C 2 -C 16 alkenyl substituted with R 20 ; pyridyl substituted with one substituent selected from R 49 , or one group from R 50 and one from R 18 ; or -T-Z; R 3 is phenyl optionally substituted with F, Cl, or methyl; R 4 is H; R 16 is 3 halogen; C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; C j^ -Ce haloalkoxy; C 2 -C 8 alkyl¬ thio; C 2 -C 8 alkenyl; or phenoxy substituted with R 29 ; R 19 is C^C^ alkylthio; C^C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 19 alkenyloxy; C 2 -C 19 alkoxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R' 43 NC (=0)0; pyridyl optionally substituted with R 31 ; or CH(=N-A-L); R 20 is C 1 -C 17 alkylthio; haloalkoxy; C -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 2 -C 17 alkoxycarbonyl; R 22 C(=0)0; R 22 0C(=0)0; R 22 R 43 NC(=0)0; C 1 -C 17 alkoxy; 1-3 halogen; or phenyl or phenoxy each optionally substituted with R 31 ; R 21 is Ci-C- j ^ alkylthio; C^C^ haloalkoxy; C 5 -C - ( 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 2 -C 17 alkoxycarbonyl; R 22 C(=0)0; R 22 0C(=0)0; R 22 R 43 NC (=o)0; C 1 -C 17 alkoxy; C 2 -C 17 alkoxyalkoxy; or phenyl or phenoxy each optionally substituted with R 31 ; R 22 is C 1 -C 16 alkyl; or phenyl optionally substituted with R 36 ; R 8 is phenyl or pyridyl each optionally substituted with R 37 ; or thienyl optionally substituted with R 38 ; R 29 , R 38 , R 42 , and R 44 are independently 1-2 halogen selected from the group consisting of F and Cl; C- L -C 4 alkyl; or C Σ -C alkoxy; R 31 , R 36 , R 37 , and R 41 are independently trifluoro¬ methyl; 1-2 halogen; cyano; C 1 -C 4 alkyl; C 1 -C 4 alkoxy; or phenoxy substituted with R 44 ; R 40 is pyridyl substituted with R 37 ; or thienyl optionally substituted with R 38 ; R 49 is C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; C 2 -C 8 alkylthio; or thienyloxy optionally substituted with R 38 ; R 50 is C 1 -C 6 alkyl; C x -C 6 haloalkyl; C^C alkoxy; C j^ -Cg haloalkoxy; C j^ -Cg alkylthio; C 2 -C 6 alkenyl; C 3 -C 6 alkenyloxy; C 3 -C 6 cycloalkyloxy; C -Cg alkox carbonyl; or -OR 28 ; R 57 is C T^ -C^ alkyl; phenyl or pyridyl optionally substituted with R4 1 ; or thienyl optionally substituted with R 42 ; A is 0 or NH; L is C^-Cs alkyl; phenylmethyl; or phenyl; T is phenyl optionally substituted with 1-2 halogen selected from the group consisting of F and Cl, or C χ -C 2 alkyl; W is 0 or S; and Z is phenoxy optionally substituted with R 16 ; -C(=0)OR 57 ; -0C(=0)R 57 ; -OR 40 ; or -OC(=0)NHR 57 . Even more preferred are the compounds of Preferred 3 that are the compounds of Preferred 2 wherein: Preferred 3 : R 2 is C 7 -C 12 alkyl; C 7 -C 12 haloalkyl comprised of fewer than 7 halogens from the group consisting of F and Cl; C 3 -C 8 alkyl substituted with phenoxy optionally substituted with R 31 ; C 1 -C 12 alkyl substituted with R 19 ; C7~C 12 alkoxyalkyl; C 7 -C 12 alkenyl; C 2 -C 12 alkenyl substituted with ,R 20 ; pyridyl substituted with one substituent selected from R 49 , or one group from R 50 and one from R 18 ; or -T-Z; R 18 is F, Cl, Br, or methoxy; R 19 is C 1 -C 12 alkylthio; C 5 -C 6 cycloalkyloxy; pyridyloxy optionally substituted with R 31 ; or CH (=N-A-L) ; R 20 is C x -C 12 alkylthio; C 5 -C 6 cycloalkyloxy; C x -C 12 alkoxy; 1-3 halogen; phenyl or phenoxy each optionally substituted with R 31 ; R 31 , R 37 , and R 41 are 1-2 halogen selected from the group consisting of F and Cl; cyano, C 1 -C alkyl, or C 1 -C 4 alkoxy; or phenoxy; R 38 is 1-2 halogen selected from the group consisting of F and Cl; methyl; or methoxy; R 49 is C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; or C -C 8 alkylthio; R 50 s C j^ -Cg alkyl; C^Cg haloalkyl; C^Cg alkoxy; C^Cg alkylthio; C 3 -C 6 cycloalkyloxy; or phenoxy optionally substituted with R 37 ; R 57 is C 1 -C 8 alkyl; or phenyl optionally substituted with R 41 ; L is C_-C 8 alkyl or phenylmethyl when A is 0; or C 1 -C 8 alkyl or phenyl when A is NH; T is phenyl optionally substituted with fluorine or methyl; and Z is -OC(=0)R 57 or -OR 40 . Especially preferred are the compounds of Preferred 4 that are the compounds of Preferred 3 wherein: Pre erred 4: R 2 is C 7 -C 12 alkyl; C 7 -C 12 haloalkyl; C 4 -C 6 alkyl substituted with phenoxy optionally substituted with R 31 ; C]_-C 12 alkyl substituted with R 19 ; C 7 -C 12 alkoxyalkyl; C 7 -C 12 alkenyl; pyridyl substituted with one group from R 50 and one halogen from the group consisting of F and Cl; or -T-Z; R 19 is C 1 -C 19 alkylthio; C 5 -C 6 cycloalkyloxy; or pyridyloxy optionally substituted with R 31 ; R 50 is C ;L -C alkyl; trifluoromethyl; C^Cg alkoxy; or phenoxy optionally substituted with R 37 ; and R 57 is Ci-Cg alkyl; or phenyl optionally substituted with R 41 . Specifically preferred for greatest fungicidal activity and/or ease of synthesis are: 5-methyl-5-octyl-3- (phenylamino) -2,4-oxazolidine- dione and the (S)-enantiomer thereof; 5- (2-fluoro-6-phenoxy-3-pyridinyl) -5-methyl-3- (phenylamino)-2,4-oxazolidinedione and the (S) -enantiomer thereof; 5-methyl-5- (3-phenoxypropyl)-3- (phenylamino)- 2,4-oxazolidinedione and the (S) -enantiomer thereof; A->[5-methyl-2, 4-dioxo-3- (phenylamino) -5- oxazolidinyl]phenyl 3-chlorobenzoate and the (S) -enantiomer thereof; and 4-[5-methy1-2, 4-dioxo-3-(phenylamino) -5- oxazolidinyl]phenyl 4-cyanobenzoate and the (S) -enantiomer thereof. When R 1 and R 2 of the compounds of Formula I are different, the compounds of Formula I possess a chiral center. This invention therefore, comprises racemic mixtures, enriched mixtures, and pure enantiomers. Compounds of Formula I can also exist as a mixture of (E)- and (_?)-imine isomers when W = N-Q-R 58 . This invention, therefore, also comprises mixtures of geometric isomers as well as the individual isomers. It is recognized that some reagents and reaction conditions described below for preparing compounds of Formula I may not be compatible with some functionalities claimed for W, R 1 , R 2 , R 3 , and R . In these cases, the incorporation of protection/- deprotection sequences into the syntheses may be necessary in order to obtain the desired products. The cases in which protecting groups are necessary, and which protecting groups to use, will be apparent to one skilled in chemical synthesis. The compounds of Formula I can be prepared as described below in the following Equations . Compounds denoted la through If are subsets of Formula I. 2-Thioxo-4-oxazolidinones la can be prepared by one or both of the Methods illustrated in Equation 1. These Methods are described in detail in the literature. Geffken, D.; Z. Naturforsch, 1983, 38b, 1008; Geffken, D.; Arch . Pharm . , 1982, 315, 802; and U.S. Patent 4,957,933 teach the procedures for the reactions described in Method 1 as well as the preparation of the starting thioxodioxazinones 2a. International Application (PCT) WO 90/12791 teaches the preparation of compounds of Formula la described in Method 2. Equation 1 Method 1 la Z = C ] _-C alkyl, C 3 -C 4 alkenyl, C 3 -C 12 cycloalkyl, C 6 -C 7 cycloalkylalkyl, C -C alkoxyalkyl, PhCH 2 The preparation of substituted hydrazines of Formula 3 can be accomplished by literature methods (J. Timberlake; J. Stowell; The Chemistry of the Hydrazo r Azo r and Azoxy Groups (S. Patai, Ed.) John Wiley and Sons, Ltd., London (1975), p 69; Demers, J. P.; Klaubert, D. J.; Tetrahedron Lett. 1987, 4933) . The ester group containing Z in compounds of Formula 4 can be alkyl (C ] _-C 4 ) , alkenyl (C 3 -C 4 ) , cycloalkyl (C 3 -C 12 ) , cycloalkylalkyl (C 6 -C 7 ) r alkoxyalkyl (C 2 -C ) , and phenylmethyl. Preferred for ease of synthesis and lower expense are esters in which Z is C;L-C 4 alkyl. The 2-hydroxycarboxylic acid esters of Formula 4 can be prepared by a number of methods known in the literature. (1) They can be formed from the corresponding 2-hydroxycarboxylic acids by esterification as is well known in the literature. The 2-hydroxycarboxylic acids can be prepared from ketones or aldehydes by formation of cyanohydrins, then hydrolysis, as is also known. For example, Org. Syntheses . Coll. Vol. 4, 58 (1968) teaches the preparation of atrolactic acid from acetophenone. (2) The esters can also be synthesized from aldehyde and ketone cyanohydrins by treatment with alcohols in the presence of HC1 to afford the iminoether hydrochlorides, followed by hydrolysis. (3) A third method known for preparing 2-hydroxy¬ carboxylic acids and esters involves treating 2-keto- acids or 2-keto-esters with nucleophilic-organometallic reagents such as Grignard reagents, and alkyl- and aryl-lithium reagents. For example, R. G. Salomon et al . teach the preparation of some esters of Formula 4 by the addition of aryl-Grignard reagents to pyruvate esters ( J. Org. Chem . 1982, 47, 4692) . (4) Another method described in the literature for preparing some 2-aryl-2-hydroxyesters and acids is by acylation of aromatic rings with activated carbonyl compounds in the presence of a protic or Lewis acid. Aromatic substrates capable of undergoing reactions of this type are benzene, diphenyl ether, furan and other aromatic compounds known to be of sufficient reactivity to undergo Friedel-Crafts-type reactions. In the case of mono-substituted benzene derivatives, the acylation occurs preferentially, but not necessarily exclusively, para to the point of attachment of the substituent. For example, see Org. Syntheses, Coll. Vol. 3, 326, (1955), Salomon et al., J. Org. Chem . , 1982, 47, 4692, and U.S. 4,922,010. Carbonyl compounds known to undergo this reaction include pyruvate esters and acids, glyoxylate esters and acids, and diesters of oxomalonates. The acids used in the acylation reaction can either be protic in nature, for example, a mixture of acetic and sulfuric acid, or a Lewis acid such as aluminum chloride, tin tetrachloride, titanium tetrachloride, or other Lewis acid known to effect Friedel-Crafts-type reactions. The acid can be used either catalytically or in excess. In some cases, the acid may react destructively with the carbonyl substrate and excess carbonyl compound must be used. The acylation can be conducted neat or in a solvent known by one skilled in the art to be suitable for Friedel-Crafts reactions, for example, methylene chloride, carbon disulfide, and nitrobenzene. The reaction may be conducted from -50°C to 100°C. The specific choice of acid, solvent, temperature, and reaction time will depend on the carbonyl and aromatic substrates to be reacted. Several methods are taught in the literature for the preparation of 2,4-oxazolidinediones of Formula Ib (Equations 1 and 2) . Geffken et al. (World Patent Publication WO 90/12791) discloses the preparation of Ib by treating 2b with a substituted hydrazine 3 as illustrated in Equation 1. The preparation of the starting dioxazinediones 2b is also described therein. WO 90/12791 also describes the desulfurization of 2-thioxo-4-oxazolidinones la to yield 2, 4-oxazolidine¬ diones Ib as shown in Equation 2. Suitable desulfurizing agents include aqueous OXONE® (KHS0 5 ) and aqueous silver nitrate. Equation 2 desulfurizing agent In addition, compounds of Formula Ib can be prepared by the methods outlined in Equation 3. These procedures involve treatment of a 2-hydroxycarboxylic acid ester 4 with a carbonylating agent 6 to produce compounds of Formula 5, followed by conversion of 5 to Ib by treatment with a substituted hydrazine 3. In Equation 3, U can be chlorine, 1-imidazolyl, or other suitable leaving group, and the ester group containing Z is as described above for the 2-hydroxycarboxylic esters 4 in Equation 2. Equation 3 Step 1 5a : ϋ-Cl 5b : U=l-iiriidazolyl Step 2 The compounds of Formula 5 can be prepared by the method illustrated in Step 1, Equation 3. For the preparation of the compounds of Formula 5a (U=C1) , the alcohols of Formula 4 are dissolved in an inert solvent such as methylene chloride or 1-chlorobutane, and treated with a tertiary-amine base such as triethylaitiine, pyridine, and N Λ N-diisopropylethylamine, at a temperature from -60°C to +30°C. To this mixture is added phosgene (6a) to provide products of Formula 5a. The phosgene can be added as a gas or dissolved in a inert solvent such as toluene and added in solution. When the reaction of Step 1 is complete, the resulting mixture is poured into a water-immiscible solvent and washed with dilute aqueous mineral acid, water, and brine. The organic liquid phase is dried and evaporated to yield products of Formula 5a. The compounds represented by Formula 5b (U = 1-imidazolyl) can be prepared using 1, 1'-carbonyl- diimidazole (CDI, 6b) as described below. The alcohols of Formula 4 are dissolved in an inert solvent in which the CDI has sufficient solubility at the reaction temperature. Methylene chloride, 1-chlorobutane and toluene are three of many suitable inert solvents . The CDI is added as a solid or as a solution in an inert solvent at temperatures from 0°C to 100°C. When the synthesis reaction is complete, the resulting mixture is poured into a water-immiscible solvent and washed successively with dilute mineral acid, water, and brine. The organic liquid phase of this mixture is separated, dried, and evaporated to isolate the product. In some cases, isolation of compounds of Formula 5 is not necessary. For example, after the formation of 5 is complete, the compounds can be treated in situ with a hydrazine of Formula 3 as described below for Step 2. Furthermore, the use of pure, isolated CDI is not necessary in the synthesis of 5b described in Equation 3, Step 1. The CDI can be first prepared, for example by treatment of a solution of imidazole in an inert solvent with phosgene as described by Staab and Wendel (Org. Syntheses. Coll. Vol. 5, 201, (1973)), and then treated in situ with alcohols 4 to afford 5b. As illustrated in Step 2 of Equation 3, compounds of Formula 5 can be dissolved in an inert solvent such as methylene chloride, 1-chlorobutane, or THF and treated with a hydrazine of Formula 3 at a temperature from 0°C to 80°C. When U is Cl as shown in Formula 5a, about one equivalent of a tertiary-amine base such as triethylamine, N, N-diethylaniline, N^ N-diisopropyl- ethylamine, or a second equivalent of a hydrazine 3 can be added. When U=l-imidazole as in Formula 5b, about one equivalent of a carboxylic acid can be added to accelerate the reaction. Suitable carboxylic acids include acetic acid, pivalic acid, and benzoic acid. Upon completion of the reaction of Step 2, the product of Formula Ib can be isolated by evaporation of the aforementioned inert solvent, and purified by dissolving the residue in a water-immiscible solvent such as ether or methylene chloride, washing with mineral acid, aqueous base, and water, drying, and evaporating the extraction solvent. Crystallization or chromatography can be utilized for additional purification if desired. For reasons of higher yields and lower expense, the methods of preparing compounds of Formula Ib from compounds of Formula 5b (U = 1-imidazolyl) are preferred to the methods of preparing Ib from 5a. Compounds of Formula lc wherein in W is N-Q-R 12 can be synthesized according to the method schematically illustrated in Equation 4. The 2-thioxo-4-oxazoli- dinones la are treated with a hydrazine (Q=NR 11 ) , hydroxylamine (Q=0) , or primary amine (Q=a direct bond) of Formula 7 Equation ' 4 la l c As shown in Equation 4, the 2-thioxo-4-oxazoli- dinones la are dissolved in an inert solvent such as methylene chloride, tetrahydrofuran (THF) , ethanol or benzene and treated with the hydrazine (Q=NR 1:L ) , hydroxylamine (Q=0) or primary amine (Q=direct bond) sometimes used in excess, at temperatures from 0°C to 80°C. Acid salts of the hydrazine, hydroxylamine or amine such as dimethylhydrazine hydrochloride and hydroxylamine hydrochloride may also be used, and in these cases an equivalent of additional base is necessary. Triethylamine, N / - N-diisopropylethylamine and other tertiary amine bases are preferred. The products lc can be isolated by evaporation of the solvent and dissolving the residue in a water- immiscible solvent such as ether. This solution may then be washed with mineral acid, water, and brine, and dried. Evaporation of the solvent followed by crystallization or chromatography affords the purified products lc. The hydrazines of Formula 7 (Q=NR 1:L ) are commercially available or can be prepared by methods referenced above for the preparation of hydrazines 3. The preparation of the hydroxylamines like 7 (Q=0) can also be accomplished by methods known in the art. See, for example, Castellino, A. J., et al. J. Org. Chem . 1984, 49, 1348; Murray, R. W., et al . Synthetic Comm . 1989, 19, 3509 and references cited therein; and Baldol, C, et al. Synthesis 1988, 344. Compounds of Formula Id wherein R 58 is C(=0)R 13 , - C(=0)OR 13 , or C(=0)NR 13 R 30 and R 30 is not hydrogen, can be prepared by treating compounds of Formula le with the appropriate acylating agent of Formula 8 as set forth in Equation 5. E uation 5 NR 13 R 30 (R 30 ≠ H) In Equation 5, the group X in the compounds of Formula 8 may be a halogen, acetate, or other moiety known to be a leaving group in acylation reactions. Chlorine is the most commonly used leaving group X. For cases in which X=C1, the compound of Formula 8 is an acid chloride, chloroformate, or carbamoyl chloride, The iminooxazolidinones of Formula Iβ are dissolved in an inert solvent such as methylene chloride, tetrahydrofuran (THF) , or benzene and treated with 8 and a base at a temperature from 0°C to 100°C. Triethylamine, N, N-diisopropylethylamine, and other tertiary amine bases are preferred. The products of Formula Id can be isolated by evaporation of the solvent and dissolving the residue in a water-immiscible solvent such as ether. This solution may be washed with a dilute aqueous mineral acid, water, and brine, and dried. Evaporation of the solvent followed by crystallization or chromatography affords the purified products. Oxazolidinones of Formula If can be synthesized by ' reacting a compound of Formula Iθ with an isocyanate as described in Equation 6 below. Equation 6 The iminooxazolidinones of Formula Iθ are dissolved in an inert solvent such as toluene, THF, acetonitrile, or 1,2-dichloroethane and treated with an isocyanate at temperatures from 0°C to 50°C. The products of Formula If can be isolated by evaporation of the solvent, and dissolving the residue in a water-immiscible solvent such as methylene chloride. This solution may be washed with dilute aqueous mineral acid, water, brine, and dried. Evaporation of the solvent followed by crystallization or chromatography affords the products of Formula If. Specific compounds that can be made by this invention are described in the Examples and Tables which follow. These are intended to be only exemplary, and are not all-inclusive. The following are a list of abbreviations and their definitions used in the Tables and Examples which follow. Unless indicated otherwise, alkyl, alkenyl, and alkynyl radicals are the normal isomers. The numbering system for heterocyclic groups is defined in the following way. First, hetero atoms contained in the ring are given the lowest possible numbers using the accepted rules of heterocycle numbering. Then, the point of attachment of the radical is the position • assigned the highest priority. For example, the attached group at C-3 in 6-MeOC(=0)-3-pyridyl is higher priority than the MeOC(=0) substituent. Ac = acetyl Me = methyl Et = ethyl Pr = propyl Bu = butyl Bzl = benzyl BzlO = benzyloxy c = cyclo OAc = acetate CN = cyano N0 = nitro S0 2 = sulfonyl S(0) = sulfinyl PhO = phenoxy BuO = butoxy PrO = propoxy EXAMPLE 1 Preparation of methyl 2-hydroxy-2-methyldeπanoate 2-Decanone (10 mL, 52.8 mmol) was dissolved in dry methylene chloride (100 mL) , treated at room temperature with zinc iodide (0.5 g, 1.57 mmol) and then trimethylsilyl cyanide (7.74 mL, 58.0 mmol) was added dropwise. The mixture was stirred at room temperature overnight. The resulting yellow solution was then washed with saturated aqueous NaHC0 3 (1 x 100 mL) , water (3 x 100 mL) and brine (100 mL) . The organic phase was dried (MgS0 ) , and evaporated to give an orange oil. The resulting, crude trimethylsilyl cyanohydrin (14.9 g) was used in the following step. All 14.9 g of the crude trimethylsilyl cyanohydrin were dissolved in methanol (200 mL) and cooled to -78°C. Hydrogen chloride gas was introduced while maintaining a temperature of -30°C or less. When the solution became saturated as evidenced by a drop in temperature, the gas flow was halted. The solution was warmed to 0°C and allowed to stand at 0°C overnight. The reaction mixture was evaporated to a white solid, and the solid was washed with ether and dried. The iminoether hydrochloride was converted to methyl 2-hydroxy-2-methyldecanoate by dissolving in water (200 mL) and steam heating for 10 minutes. The aqueous solution was extracted with ether (2 x 150 mL) and the combined extractions were dried (MgS0 4 ) , and evaporated resulting in 8.2 g of the title compound as a colorless oil. L H NMR (CDC1 3 , 200 MHz) : δ 3.78 (s, 3H, OMe) , 3.1 (s, IH, OH), 1.4 (s, 3H, CH 3 ) , 1.26 (s, 10H) , 0.9 (t, 3H) . EXAMPLE 2 Preparation of 5-n-octyl-5-methyl-3- (phenylamino) -2.4-oxazolidinedione Methyl 2-hydroxy-2-methyldecanoate (8.3 g, 38.4 mmol) was dissolved in 1-chlorobutane (100 mL) , treated with 1, 1 '-carbonyldiimidazole (11.2 g, 69.1 mmol), and stirred overnight at room temperature. The mixture was filtered and the filtrate was washed with water (3 x 100 mL) and brine (100 mL) . The organic phase was dried (MgS0 4 ) , and evaporated to a colorless oil (11.3 g) . The resulting crude acyl imidazole (5.2 g, 16.6 mmol) was dissolved in 1-chloro¬ butane (75 mL) and treated sequentially with phenyl- hydrazine (2.5 mL, 24.9 mmol) and HOAc (1.4 mL, 24.8 mmol) . The mixture was stirred overnight at room temperature and then washed with water (3 x 100 mL) and brine. The organic phase was dried (MgSO^), and evaporated to an orange oil . The title compound was obtained as a white solid (1.87 g, mp 63°C) after two recrystallizations from hexanes . ^-H NMR (CDC1 3 , 200 MHz) : δ 7.25 (m, 2H) , 7.02 (t, IH) , 6.8 (d, 2H) , 6.02 (s, IH, NH) , 1.98 (m, 2H) , 1.6 (s, 3H, CH 3 ) , 1.26 (2, 12H), 0.88 (t, 3H) . EXAMPLE 3 Preparation of ethyl 2- C2-fluoro-6- phenoxy-3-pyridyl) -lactate To a stirred solution of lithium diisopropylamide (40 mL, 2 M, 80 mmol) in tetrahydrofuran (20 mL) at -70°C under nitrogen, a solution of 2-fluoro-6-phenox-y- pyridine (13.56 g, 71.7 mmol) in tetrahydrofuran (10 mL) was added dropwise, keeping the reaction solution temperature below -60°C. After the addition was completed, the solution was further stirred at -70°C for 1 h. Ethyl pyruvate (9.15 g, 78.8 mmol) in tetrahydrofuran (5 mL) was added dropwise, keeping the reaction temperature below -60°C. After the addition, the cool bath was removed and the reaction solution was stirred at ambient temperature. When the reaction solution temperature reached -10°C, the reaction mixture was poured into water (150 mL) . The aqueous layer was extracted with EtOAc (3 x 100 mL) . The combined organic layers were washed with water (100 mL) , dried (MgS0 4 ) , and filtered. The solvent was removed in vacuo to afford a residue which was purified by silica gel chromatography (EtOAc/hexane = 1/2) to afford an oil which upon standing turned into a wax (10 g, 45%) X H NMR (CDC1 3 ) δ 1.25 (3H, t, J=6.5 Hz), 1.82 (3H, 5), 4.0 (IH, s) , 4.20 (2H, q r J=6.5 Hz), 6.72 (IH, d, J=9 Hz), 7.15-7.55 (5H, m) , 7.97 (IH, t, J=9 Hz) . EXAMPLE 4 Preparatio of 5- f2-fluprp-6-phβnp y-3-pyridy;L) -5- methyl-3- (phenylamino) -2, 4-oxazolidinedione To a solution of ethyl 2- (2-fluoro-6-phenoxy-3- pyridyl) lactate (2 g, 6.56 mmol) in anhydrous dichloro- methane (40 mL) at room temperature, was added carbonyldiimidazole (1.6 g, 9.88 mmol) . The mixture was stirred overnight at room temperature and was then poured into water (150 mL) . The aqueous layer was extracted with EtOAc (3 x 50 mL) . The combined organic layers were washed with water, dried (MgS0 4 ) and filtered, and the solvent removed in vacuo to afford an oil. This oil was dissolved in dichloromethane (20 mL) and HOAc (0.6 g, 10 mmol) and phenylhydrazine (0.78 g, 7.2 mmol) were added. The mixture was stirred at room temperature overnight and was poured into dilute HCl (6N, 100 mL) . The aqueous layer was extracted with EtOAc (3 x 50 mL) . The combined organic extracts were washed with water (100 ml) and dried (MgS0 4 ) . The solvent was removed in vacuo to afford a residue which was recrystallized from 1-chlorobutane to afford the title compound (1.9 g, 75% yield) as a white solid, mp 175°C. R NMR (CDC1 3 ) δ 1.85 (3H, 5), 5.85 (IH, 5), 6.50-7.85 (12H, m) . EXAMPLE 5 Preparation of 5-methyl-3- .phenylamino)-5-T3- (phenoxypropyl) 1-2. -oxazolidinedione 1,1'-Carbonyldiimidazole (0.96 g, 5.9 mmol) and ethyl 2-(3-phenoxy-l-propyl)lactate (1.0 g, 3.9 mmol) were dissolved in dichloromethane (10 mL) . The reaction solution was stirred at room temperature overnight and was then added to water (20 mL) . The aqueous layer was extracted with EtOAc (3 x 50 mL) . The combined organic layers were washed with water (50 mL) , dried (MgS0 ) and filtered. The solvent was removed in vacuo to afford an oil which was dissolved in dichloromethane (20 mL) . Acetic acid (4.7 g, 7.8 mmol) and phenylhydrazine (0.62 g, 5.9 mmol) were added. The reaction mixture was stirred at room temperature overnight and then poured into dilute HCl (IN, 50 mL) . The aqueous layer was extracted with EtOAc (3 x 50 mL) . The combined organic layers were washed with water (50 mL) , dried (MgS0 4 ) and filtered. The solvent was removed in vacuo to afford a residue which was recrystallized from 1-chlorobutane to afford a white solid (1.1 g, 83%) mp 114-5°C, X H NMR (CDC1 3 ) δ 1.70 (3H,5), 1.78-2.22 (4H, m) , 3.98 (2H, t, J=6.5 Hz), 6.10 (IH, 5), 6.80-7.38 (10H, m) . EXAMPLE 6 Preparation of 2- ~ 4-(fcert-butyldimethyl- silylpxy) henylUactic acid A round-bottom flask equipped with a magnetic stirbar, addition funnel, condenser and a N 2 inlet was charged with Mg (90 mg) and the apparatus was dried under a N flow. Once cooled to room temperature, THF (1 mL) was added to the flask along with I 2 (1 mg) and BrCH 2 CH 2 Br(2 drops). To the flask was then added 2 mL of a solution of 4-t-butyldimethylsilyloxy bromobenzene (1.0 g, 3.48 mmol) in THF (12 mL) and the I 2 color discharged within 3-5 min. The remainder of the halide solution was added over a 5 min period and the resulting mixture was stirred while heated at reflux for 4 h. The flask was cooled to 0°C, sodium pyruvate (420 mg, 3.83 mmol) was added in a single portion, and the resulting mixture was stirred vigorously overnight. The resulting solid mass was broken-up, suspended in Et 2 0 (50 mL) and collected by vacuum filtration. The filter cake was washed with Et 2 0 (2 x 25 mL) , allowed to air dry and was then transferred to a flask and suspended in H 2 0 (10 mL) . After stirring for 15 min, con HCl (0.7 ml) was added along with EtOAc (25 ml) and the mixture was stirred until the phases cleared. The phases were separated and the aqueous phase was extracted with EtOAc (2 x 25 mL) . All organic phases were washed with H 2 0 (2 x 20 mL) , brine (2 x 25 mL) , combined and dried (Na 2 S0 4 ) . Solvents were evaporated in vacuo to afford the desired hydroxyacid as a light yellow, dense oil, 660 mg (66%) . i R NMR (CDC1 3 ) : δ 7.45-7.4 (d, 2H) , 6.84-6.8 (d, 2H) , 1.81 (s, 3H) , 0.98 (s, 9H) r 0.19 (s, 6H) . EXAMPLE 7 Preparation of Ethyl 2- ϊ4- ( tert- butyldimethylsilyloxy) 1 -phenyllactate To a solution of 2-[4- (tert-butyldimethyl- silyloxy) Jphenyllactatic acid (2.14 g, 7.23 mmol) in dry DMF was added N^ N-diisopropylethylamine (2.26 g, 14.46 mmol) and Etl (2.26 g, 14.46 mmol) and the resulting mixture was stirred at room temperature overnight. The mixture was diluted with Et 2 0 (100 mL) and washed with H 2 0 (4 x 40 mL) , IN aq. HCl (2 x 10 mL) , saturated aq. NaHC0 3 (1 x 30 mL) and brine (1 x 50 mL) . The aqueous washes were extracted with Et 2 0 (1 x 50 mL) and the Et 2 0 phases were combined, dried (MgS0 ) and concentrated in vacuo to afford a clear yellow oil, 2.32 g. Product was purified by column chromatography on Si0 2 to yield the lactate ester as a clear, colorless oil, 1.36 g. ^-H NMR (CDC1 3 ) : δ 7.39 (d, 2H) , 6.80 (d, 2H) , 4.24-4.20 (m, 2H) , 3.74 (s, IH) , 1.75 (s, 3H) , 1.25 (t, 3H) , 0.98 (s, 9H) , 0.19 (s, 6H) . EXAMPLE 8 Preparation of 5- (4-t-butyldimethylsilyloxyphenyl) - 5-methyl-3- phenylamino) -2.4-oxazolidinedione To a solution of ethyl 2- [4-tert-butyldimethyl- silyloxy) ]phenyllactate (7.25 g, 23.3 mmol) in BuCl (65 mL) was added 1, 1 '-carbonyldiimidazole (6.79 g, 42 mmol) and the resulting mixture was heated at reflux for 3 h. TLC indicated all starting material had been consumed. The mixture was diluted with BuCl (100 mL) and washed with H 2 0 (3 x 50 mL) and brine (1 x 75 mL) . The aqueous washes were extracted with BuCl (1 x 75 mL) and the organics were combined and dried (MgS0 4 ) . Solvent was removed in vacuo to yield an oil (9.14 g) which was dissolved in BuCl (65 mL) , treated with PhNHNH 2 (4.54 g, 42 mmol) and HOAc (2.5 L, 42 mmol) and stirred at room temperature overnight. The solution was then diluted with ether (250 mL) and washed with IN aqueous HCl (2 x 100 mL) , saturated aqueous NaHC0 3 (2 x 100 mL) , and brine (2 x 100 mL) . The aqueous washes were extracted with ether (1 x 100 mL) and the organics were combined and dried (MgS0 4 ) . Evaporation of solvent in vacuo yielded an orange solid which was washed with hot hexane to afford a faint- yellow solid, 7.07 g, (74%), m.p. 150-151°C. ^ NMR (CDC1 3 ) : δ 7.43 (d, 2H) , 7.26-7.23 ( , 2H) , 7.05-7.00 (t, IH) , 6.88 (d, 2H) , 6.73 (d, 2H) , 6.04 (s, IH) , 1.97 (s, 3H) , 0.98 (s, 3H) , 0.21 (s, 6H) . EXAMPLE 9 Preparation of 5- 4-hydroxyphenyl) -5-methyl- 3- (phenylamino) -2 r 4-oxazolidinedione To a solution of the 5- (4-t-butyldimethylsilyloxy- phenyl) -5-methyl-3- (phenylamino) -2, 4-oxazolidinedione (3.75 g, 9.1 mmol) in CH 3 CN (50 mL) was added 47% aqueous HF (1 mL) and the resulting mixture was stirred overnight. Acid was quenched by the addition of saturated aqueous NaHC0 3 (50 mL) , diluted with H 2 0 (30 mL) and extracted with Et 2 0 (3 x 100 mL) . The extracts were washed with brine (1 x 75 mL) , combined and dried (MgS0 4 ) . Evaporation of solvents in vacuo yielded crude material as an oil which solidified upon standing (3.09 g) , m.p. 171-174°C. IR (mineral oil) : 3270, 3263, 1817, 1744 cm "1 ; X H NMR (CDC1 3 ) : δ 8.84 (s, IH), 7.78 (s, IH) , 7.44 (d, 2H) , 7.24 (t, 2H) , 6.98-6.85 (m, 3H) , 6.80 (d, 2H) , 2.00 (s, 3H) . EXAMPLE 10 Preparation of 5- (4-cyanobenzolyloxy) - 5-methyl-3-(phenylamino) -2 r 4-oxazolidinedione A flask containing 5- (4-hydroxyphenyl) -5-methyl-3- (phenylamino) -2, 4-oxazolidinedione (800 mg, 2.68 mmol) in THF (14 mL) under an N 2 atmosphere was cooled to 0°C and to the stirred solution was sequentially added N / .N-diisopropylethylamine (4.33 mg r 3.35 mmol) and 4-cyanobenzoyl chloride (465 mg, 3.35 mmol) . The resulting mixture was stirred for 1.5 h at which time the reaction was complete as determined by TLC. The solution was diluted with Et 2 0 (100 mL) and sequentially washed with IN aqueous HCl (2 x 30 mL) saturated aqueous NaHC0 3 (1 x 50 mL) and brine (2 x 50 L) . The washes were extracted with Et 2 0 (2 x 50 L) and the ether phases were combined and dried (MgS0 ) . Evaporation of solvents in vacuo afforded crude material as a tan-colored solid, 1.08 g. Purification was effected by column chromatography on Si0 2 (30 g) eluting with methylene chloride to return white solid, 950 mg, m.p. 180-182°C. i -K NMR (CDC1 3 ) : 8.34-8.30 (d, 2H) , 7.86-7.82 (d) , 7.74-7.7 (d, 2H) ; 7.34-7.23 (t, 4H) , 7.06-7.02 (t, IH) , 6.78-6.74 (d r 2H) , 6.07 (s, IH) , 2.03 (s, 3H) . The compounds illustrated below are subsets of compounds of Formula I referred to in Tables 1-45 which follow. The groups R^—R 59 and A, E, V, G, J, L, m, n, Q, T, W, Y, and Z are as defined in Formula I in the Summary of the Invention. Additional variables are used in the compounds and Tables and are: R 60 , which is a structural component of some R 19 groups, is R 22 , R 22 0, or R 22 R 43 N; R 61 and R 62 , which are the substituents on T, are each independently halogen, Ci-C ^j alkyl, C ! -C 4 alkoxy, trifluoromethyl, thiomethyl, or nitro; R 63 , which is a structural component of some G groups, is R 52 or R 37 ; E 1 , which is a structural component of some G groups, is 0, S, or NH; p, which designates the size of a portion of some substituted R 2 alkyl groups, is 1-18; q, which designates the size of a portion of other substituted R 2 alkyl groups, is 1-19; and r and t designate the length of some alkoxyalkyl R 2 groups. The sum of r and t is 2-20. Ig II Im lo IP iq Ix Ir Is It lu Iv Iw ΪA£ E_i T&£ SLnZ Compounds of Formula I wherein Compounds of Formula I wherein W=S, W=S Λ R 2 =2-F-6-PhO-3-pyridinyl, R 1 =Me, and R 2 =2-F-6-Ph0-3-pyridinyl R 3 =Ph r and R=H S 1 B 4 H 2-Me-Ph H Me 4-F-Ph H Et 3-Cl-Ph H n-butyl 4-Me-Ph H CF 3 3-MeO-Ph H cyclopropyl 4-CF 3 0-Ph H CH 2 =CH 2-Me-3-Cl-Ph H C0 2 CH 3 2-F-3-Cl-Ph H PhCH 2 2,4-diMe-Ph H 4'-F-Bzl Ph Me 3'-Me-Bzl Ph Ac 4'-MeO-Bzl TABLE 3 TA£L£_4. Compounds of Formula I wherein Compounds of Formula I wherein W=0, W=0, R 2 =2-F-6-PhO-3-pyridinyl, R 1 =Me, and R 2 =2-F-6-PhO-3-pyridinyl R 3 =Ph, and R 4 =H E 1 H Me Et ji-butyl CF 3 CF CH 2 CH 2 CH 2 cyclopropyl cyclohexyl CH 2 =CH CH 2 =CHCH 2 C0 2 CH 3 n-propyloxy-carbonyl PhCH 2 PhC(CH 3 )H 4'-F-Bzl 3'-Me-Bzl 4'-CF 3 -Bzl 4'-MeO-Bzl 4'-MeS-Bzl rein W=S, TABLS 7 T£LE_8_ Compounds of Formula I wherein Compounds of Formula I wherein W=0, W=0, R 2 =n-octyl, R 3 =Ph, R 1 =Me, and R 2 =n-octyl and R 4 =H E 1 E- B « H Me Et n-butyl CF 3 CF 3 CH 2 CH 2 CH 2 cyclopropyl cyclohexyl CH =CH CH 2 =CHCH 2 C0 2 CH 3 ij-propyloxy-carbonyl PhCH 2 PhC(CH 3 )H 4'-F-Bzl 3 « -Me-Bzl 4'-CF 3 -Bzl 4'-MeO-Bzl 4'-MeS-Bzl TABLE 9 TABLE 10 Compounds of Formula I wherein Compounds of Formula I wherein W=S, =S, R 2 =4-(3-Cl-benzoyloxy)Ph, R.l=Me, and R 2 =4-(3-Cl-benzoyloxy)Ph R 3 =Ph, and R 4 =H E 1 E- E q H Me Et n-butyl CF 3 cyclopropyl CH 2 =CH C0 2 CH 3 PhCH 2 4'-F-Bzl 3'-Me-Bzl 4 r -MeO-Bzl rein - TABLE 13 TABLE 14 Compounds of Formula I wherein Compounds of Formula I wherein R 1 =Me r R 3 =Ph, and R 4 =H W=N-0-R 58 , R^Me, R 2 =2-F-6-PhO- 3-pyridinyl, R 3 =Ph Λ and R 4 =H E^ H E 58 2-F-6-PhO-3-pyridinyl N-OH n-octyl n-octyl N-OH CH 2 =CHCH 2 4- (3-Cl-benzoyloxy) Ph N-OH Bzl 2-F-6-PhO-3-pyridinyl N-OMe Ph n-octyl N-OMe Me0 2 CCH 2 4- (3-Cl-benzoyloxy) Ph N-OMe 4-F-Ph 2-F- 6-PhO- 3-py idinyl N-OAc 4-Me-Ph n-octyl N-OAc 4-MeO-Ph 4- (3-Cl-benzoyloxy) Ph N-OAc hexanoyl 2-F-6-Ph0-3-pyridinyl N-0 (C=0) OMe PhC-=0 n-octyl N-0 (C=0) OMe (4-Me-Ph)C«0 4- (3-Cl-benzoyloxy) Ph N-0 (C=0) OMe PhCH 2 C=0 2-F-6-PhO-3-pyridinyl N-0 (C=0) NHPh (4-MeO-Ph)CH 2 C=0 n-octyl N-0 (C=0) NHPh (cyclohexyl)O=0 4- (3-Cl-benzoyloxy) Ph N-0 (C=0) NHPh hexyloxycarbonyl 2-F-6-Ph0-3-pyridinyl NH (cyclohexyl)OC-O n-octyl NH PhOC-O 4- (3-Cl-benzoyloxy) Ph NH (4-Me-PhO)C=0 l 0 5-PhO-2- naphthalenyl 0 5-PhO-2- naphthalenyl 0 5-PhO-l- naphthalenyl 0 4-(2-MeS-PhO)- 2- naphthalenyl 0 2-pyridyl 0 2-pyridyl O 3-pyridyl O 4-pyridyl O 5-CF 3 -2-pyridyl ' 0 5-CF 3 -2-pyridyl 0 3-F-2-pyridyl O 2-furanyl 0 2-furanyl 0 3-furanyl O 3,5-diMe-2- furanyl O 2-thienyl 0 2-thienyl 0 3-thienyl 0 4-Cl-2-thienyl 0 5-F-3-thienyl TABLE 24 Compounds of Formula II wherein: V £ 39 E 57 3-(0(C=V)NR 39 R 57 ) O Me Me 4-(O(C=V)NR 39 R 57 ) O H 3-pentyl 4-(O(C=V)NR 39 R 57 ) O Me 4-Et-hexyl 4-(O(C=V)NR 39 R 57 ) O i-Pr decyl 4-pyridyl 3-Cl-2-pyridyl 3-CN-2-pyridyl 5-Cl-4-Me-3-furanyl 4-Me0-2-thienyl 5-CF 3 -2-thienyl TABLE 25 Compounds of Formula II wherein: 3 --OORR 40 4-MeS-3-Me-2-thienyl 3-OR 40 1-naphthalenyl 4-OR 40 2-naphthalenyl 4-OR 40 4-F-6-N0 2 -l- naphthalenyl 3-OR 40 7-methyl-2- naphthalenyl 4-OR 40 4-i-butoxy-6-MeS-7- naphthalenyl 4-OR 40 2-imidazolyl 3-OR 40 4-imidazolyl 4-OR 40 4-Me-4-imidazolyl 4-OR 40 4,5-diBr-2- imidazolyl 4-OR 40 5-CF -3-imidazolyl 3-OR 40 3-pyrazolyl 4-OR 40 3-pyrazolyl 4-OR 40 4-F-3-pyrazolyl 3-OR 40 5-CF 3 -4-N0 2 -3- pyrazolyl 4-OR 40 5-Br-4-Me0-3- pyrazolyl 4-OR 40 2-oxazolyl 3-OR 40 5-oxazolyl 4-OR 40 4-CF 3 -2-oxazolyl 4-OR 40 5-MeS-2-oxazolyl 3-OR 40 5-N0 2 -4-Me-2- oxazolyl 4-OR 40 2-thiazolyl 3-OR 40 4-CF 3 -5-Me-2- thiazolyl 4-OR 40 5-N0 -2-thiazolyl 4-OR 40 4-Et-2-thiazolyl 3-OR 40 3-isoxazolyl 4-OR 40 5-isoxazolyl isothiazolyl 5-F 5-C1 5-F 3-Br TABLE 28 4-F-7-Me-l-naphthalenyl 2-imidazolyl 5-CF 3 -2-imidazolyl 3-pyrazolyl 4-N0 2 -2-pyrazolyl 5-oxazolyl 5-MeS-2-oxazolyl 2-thiazolyl 4-Et-3-thiazolyl 3-isoxazolyl 3-isothiazolyl 5-propyl-3-isothiazolyl TABLE 29 Compound of Formula lo wherein: 2-F Me 3-pentyl 3-N0 2 H 2-F-4-Me-heptyl 4-MeS Et (Z)-4-Br-2-butenyl 3-CF 3 Me 4-F-Ph 4-Br Pr 3-CF 3 -Ph 3-C1 H 2-MeO-5-CN-Ph 2-F Me 3-(3-CF 3 0-PhO)Ph 3-Br Et 3-Cl-2-pyridyl 2-F Pr 4-F-3-furanyl 4-EtO Et 2-thienyl 3-C1 2-F Me 4-MeO-2-thienyl 2-F Me 3-pentyl 2-F Me cyclohexyl 3-Br 2-F H 2-propenyl 4-MeS Et (Z)-4-Br-2-butenyl 6-F H 3-Cl-Ph 3-CF 3 Me 4-F-Ph 4-Br Pr 3-CF 3 -Ph 3-N0 2 H 4-t-Bu-Ph 3-N0 2 H 4-t-Bu-Ph 4-((C=V)NR 39 R 57 O H 2-MeO-5-CN-Ph 4-((C=V)NR 39 R 57 O Et 3-Cl-2-pyridyl 3-( (C=V)NR 39 R 57 S H 5-CF 3 -3-pyridyl 4-( (C=V)NR 39 R 57 S Pr 4-F-3-furanyl 3-((C=V)NR 39 R 57 O Et 2-thienyl 4-( (C=V)NR 39 R 57 O Me 4-MeO-2-thienyl TABLE 30 Compounds of Formula lo wherein: E 61 E 62 Z. n E 59 6-F 2-F 3-(CH 2 ) I1 R 59 3 Ph 2-F 4-(CH 2 ) n ] ,59 3 Ph 3-MeO 4-(CH 2 ) n l ,59 4 Ph 4-CF 3 3- (CH 2 ,59 3 3-Cl-Ph 2-F 4-(CH 2 , n . ,59 4 - 4-F-Ph 4-MeS 3-(CH 2 , n . ,59 3 4-Br-2-F-Ph 5-C1 2-F 3-(CH 2/n - I. 59 3 2-Me-Ph 5-i-Pr 3-(CH 2/n ,,59 4 3-ϊ-Pr-Ph 2-F 4-(CH 2;ιl , ,59 3 4-t-Bu-Ph 4-Me 3-<CH 2 , n , ,59 3 3-EtO-Ph 2-F 3-(CH 2/n . ^59 4 2-CF 3 -4-EtO-Ph 3-EtO 4-(CH 2/ni ,59 4 3-N0 2 -5-F-Ph 6-F 2-F 3-0(CH 2 ) n R 59 3 Ph 4-Br 3-0(CH 2 ) n R 59 4 Ph 2-F 4-0(CH 2 ) n R5- 9 3 Ph .2-F 4-0(CH 2 ) n R ; 59 4 4-F-Ph 5-C1 2-F 3-0(CH 2 ) n R 59 3 2-Me-Ph 2-F 4-0(CH 2 ) n R 59 3 4-t-Bu-Ph 5-Me 3-0(CH 2 ) n R ; 59 3 3-EtO-Ph 2-F 3-0(CH 2 ) n R59 4 2-CF 3 -4-EtO-Ph 5-CF 3 3-0(CH 2 ) n R : 59 4 2-MeS-4-Bu-Ph 6-F 2-F 3-(CH 2 ) n -OR 59 3 Ph 2-F 4-(CH 2 ) n -OR 59 3 Ph 3-MeO 4-(CH 2 ) n -OR 59 4 Ph 2-F 5-i-Pr 2-F 4-Me 2-F 5-CF TABLE 31 Compounds of Formula I wherein W=0, R 1 =CH 3 , R 3 =Ph, R 4 =H, and: idyl 3- )-3- - (C (Cl) 2 =CHCH 2 0) -2-pyridyl 2-(Me(CH 2 ) 3 CH(Me) )-5-F- - (EtOCH 2 0) -2-pyridyl oxazolyl - (C 5 H 1:L ) -2-pyridyl 2-EtO-4-oxazolyl -CF 3 0-2-pyridyl 2-(3-CF 3 -PhO)-4-oxazolyl - (CC1 3 CH 2 S) -2-pyridyl 2-Me-4-F-5-oxazolyl - (C1CH 2 CH=CHCH 2 ) -2-pyridyl 2-EtO-5-oxazolyl -MeS0 2 -2-pyridyl 2-hexyl-4-F-5-oxazolyl - (CgH-L!) -2-pyridyl 2-CF 3 -5-oxazolyl - (CH (CH 3 ) 2 (CH 2 ) 3 ) -2-pyridyl 2-thiazolyl - (C1CH 2 CH 2 ) -2-pyridyl 4-F-5-Me-2-thiazolyl -CF 3 0-2-pyridyl 4-MeO-5-CF 3 -2-thiazolyl - (C 5 H 1;L 0) -2-pyridyl 4-(Me(CH 2 ) 3 CH(Me) )-5-EtO-2- -EtS-2-pyridyl thiazolyl -CF 3 S-2-pyridyl 4-hexyloxy-5-Cl-2-thiazolyl -(CBr 2 =CH)-2-pyridyl 5-(2-Me-PhO)-2-thiazolyl -(MeC≡C)-2-pyridyl 2-Cl-4-thiazolyl -(CH 2 =CHCH 2 0)-2-pyridyl 2-Me-5-F-4-thiazolyl -MeS0 2 -2-pyridyl 2-EtO-4-thiazolyl -(MeOCH 2 0)-2-pyridyl 2-Cl-5-F-4-thiazolyl -CF 3 0-4-pyridyl 2-Br-5-thiazolyl -(MeC≡C)-4-pyridyl 4-F-5-thiaz lyl -EtS0 2 -4-pyridyl 2-hexyl-5-thiazolyl -F-2-PhO-4-pyridyl 2-Et-4-F-5-thiazolyl -F-2-PhO-4-pyridyl 2-Br-4-F-5-thiazolyl -C1-2-(2-F-PhO)-4-pyridyl 5-Cl-3-isoxazolyl -(2-F-PhO)-6-Me-4-pyridyl 4-F-5-Me-3-isoxazolyl -Br-2-oxazolyl 4-F-5-hexyloxy-3-isoxazolyl -Et-5-Me-2-oxazolyl 5-MeO-3-isoxazolyl -(Et 2 CHO)-5-Cl-2-oxazolyl 5-(4-EtO-PhO)-3-isoxazolyl -Me-5-CF 3 -2-oxazolyl 4-isoxazolyl -F-5-MeO-2-oxazolyl 5-F-4-isoxazolyl -(2-Me-PhO)-2-oxazolyl 3-F-4-isoxazolyl -(4-Cl-PhO)-5-EtO-2-oxazolyl 3,5-diF-4-isoxazolyl -hexyl—4-oxazolyl 3-hexyl-5-isoxazolyl -Br-5-F-oxazolyl 3-Br-4-F-5-isoxazolyl -Me-4-oxazolyl 3-(Et CHO)-5-isoxazolyl -Et-4-F-5-isoxazolyl -CF 3 -5-isoxazolyl -(4-F-PhO)-5-isoxazolyl -(4-Br-PhO)-4-F-5-isoxazolyl -Cl-3-isothiazolyl -F-5-Me-3-isothiazolyl -hexyloxy-3-isothiazolyl -F-3-isothiazolyl -F-5-MeO-3-isothiazolyl -(2-Me-BzlO)-3-isothiazolyl -isothiazolyl -F-4-isothiazolyl -F-4-isothiazolyl ,5-diF-4-isothiazolyl -Br-5-isothiazolyl -MeO-4-F-5-isothiazolyl -CF 3 -5-isothiazolyl -(Me(CH 2 ) 2 CH(Et) )-4-F-5- isothiazolyl -Cl-4-F-5-isothiazolyl -(2-MeO-BzlO)-4-F-5- isothiazolyl -(4-F-PhO)-5-isothiazolyl -(3-Et-BzlO)-5-isothiazolyl -(4-Br-PhO)-5-isothiazolyl -pyrazinyl -Br-6-MeO-2-pyrazinyl -hexyl-6-Me-2-pyrazinyl -(2-Cl-PhO)-3-F-2-pyrazinyl -(3-Me-PhO)-2-pyrazinyl -(4-EtO-BzlO)-3-F-2-pyrazinyl -pyridazιnyl -hexyloxy-5-Me-3-pyridazinyl -Cl-5-MeO-3-pyridazinyl -hexyl-4-F-3-pyridazinyl -(2-F-BzlO)-3-pyridazinyl Formula Ip 5- (3-thienylthio) 6-(2-F-3-thienylthio) 6-(4-Br-3-thienylthio) 6-(2-Me-4-thienylthio) 5-(4-CF 3 -3-furanylthio) 6-(3-furanylthio) 6-(2-Cl-3-furanylthio) 6-(2-Me-4-furanylthio) 5-(5-Cl-4-isoxazolylthio) 6-(5-Me-3-isoxazolylthio) 6-(3-isoxazolylthio) 5- (2-oxazolylthio) 6-(2-Cl-3-oxazolylthio) 5-(5-F-3-pyrazolylthio) 6-(3-Br-4-pyrazolylthio) 5-(2-F-4-pyridylamino) 6-(6-Me-2-pyridylamino) 6-(3-pyridylamino) 5-(2-CF 3 -3-thienylamino) 6-(2,5-diF-3-thienylart-ino) 5-(4-Me-3-furanylamino) 6-(3-furanylamino) 5-(5-MeO-3-isoxazolylamino) 6-(3-CF 3 -4-isoxazolylamino) 5-(2-EtS-4-oxazolylamino) 6-(3-N0 2 -4-pyrazolylamino) TABLS 35 Compounds of Formula Is wherein: ≤ 2-(2,4,6-triF-PhO) 2-PhO 2-(4-CF 3 0-PhO) 2-(5-CF 3 -3-thienyloxy) 2-(2-Cl-3-furanyloxy) 2-(2-oxazo yloxy) 2-(4 r 5-diCl-2-oxazolylthio) 2-(4-Me-3-isoxazloyloxy) 2-(4-F-3-pyrazolylthio) 2-(2,4,6-triF-PhS) 2-(3-pyridylamino) 2-(4-CF 3 0-PhS) 2-(2,5-diF-3-thienylamino) 2-(2-F-3-pyridylthio) 2-(2-Me-3-furanylamino) 2-(5-Me-2-pyrimidylthio) 2-(5-MeO-3-isoxazolylamino) 2-(3-thienylthio) 2-(2-CF 3 -2-oxazolylamino) 2-(2-Cl-3-furanylthio) 2-(5-Me-3-pyrazolylamino) 4-(3-isoxazolylthio) TABLE 36 Compounds of Formula Iq wherein: £ E 28 5-(R 28 NMe) 2-(Me0C(=0)Ph 5-(R 28 NMey 3-(2-F-PhO)Ph 5-(R 28 NMe) 6-F-2-pyridyl 5-(R 28 NMe) ' 4-F-2-pyrimidyl 5-(R 28 NMe) 5-MeS-2-thienyl 5-(R 28 NMe) 2-N0 2 -3-furanyl 5-(R 28 NMe) 3-CF 3 -4-isoxazolyl (Z)-5-(R 28 CH=CH) 2-F-Ph 5-(R 28 CH=CH) 3-Me-2-furanyl 5-(R 28 0C(=O) 4-PhO-Ph 5-(R 28 OC(=S) 4-Cl-Ph 5-(R 28 OC<=S) 5-MeO-2-pyrimidyl 5-(R 28 OC(=S) 3-F-pyrazolyl 5-(R 28 C(= )0 2,4-diF-Ph 5-(R 28 C(=S)0 ' 2-furanyl 5-(R 28 N(C 3 H 7 )C(=S)O) 2,5-diCl-3-thienyl 5-(R 28 0C(=S)0) 3-isoxazolyl 5-(R 28 NHC(=0)O) 4-Me-2-imidazolyl 5-(R 28 (Et)C(=S)O) 5-MeS-3-pyrazolyl 6-(R 28 NMe) 4-CF 3 0-Ph 6-(R 28 NMe) 4-pyridyl 6-(R 28 NMe) 2-Cl-4-pyrimidyl 6-(R 28 NMe) 3-N0 2 -2-thienyl 6-(R 28 NMe) 4-F-2-furanyl 2-Me-4-pyrazolyl 3-pyridyl 4-Cl-2-oxazolyl 5-F-3-pyrazolyl 4-Et-Ph 2,5-diCl-3-thienyl 4-oxazolyl 3-MeO-Ph 3-Me-pyrazolyl 3-furanyl 5-MeS-3-isoxazolyl 5-F-3-pyrazolyl 6-Br-2-pyridyl 2-oxazolyl Ph 6-Me-2-pyridyl 4-pyrimidyl 4-Br-3-thienyl 3-CF 3 -2-furanyl 2-Cl-4-oxazolyl 4-Et-Ph 2-thienyl 3-Cl-Ph 6-F-2-pyridyl 3-furanyl 3-N0 2 -Ph 2,5-diCl-3-thienyl 5-CF -3-isoxazolyl 2-PhO-5-pyrimidyl 6-(MeOC(=0)-2-pyridyl 2-oxazolyl 2-thienyl E 59 5-(R 59 0(CH 2 ) 4 ) 2-pyrimidyl 5-(R 59 OCH 2 ) 4-N0 2 -2-oxazolyl 5- (R 59 (CH 2 ) 4 0) 2-furanyl 5- (R 59 CH 2 0) 2 -Cl- 4 -pyrimidyl 5-(R 59 CH 2 ) 4-Me-Ph 5- (4-N0 2 -Ph) 6- (R 59 0 (CH 2 ) ) 2-Me-3-f uranyl 6-(R 59 CH 2 0) 3-thienyl 6-(R 59 (CH 2 ) 2 ) 5-MeS-2-oxazolyl 6- (3-MeS-Ph) 4-(R 59 0(CH 2 ) 3 ) 4,5-diCl-pyrazo yl 4-(R 59 (CH 2 ) 2 0) 5-Me-3-isoxazolyl 3-Cl-Ph 3-Me-4-pyridyl 2-pyrimidyl 2-Et-3-thienyl 3-furanyl 4-Me-2-oxazolyl 5-N0 2 -3-pyrazolyl 4-Cl-Ph 6-Me-2-ρyridyl Ph 4-EtO-2-pyridyl 3-F-2-oxazolyl 4-Br-Ph 6-Et-2-pyridyl 4-CF 3 -Ph 2-oxazolyl 4-CF 3 -2-pyrimidyl 5-Me-2-furanyl E 59 3-F-Ph 3-isoxazolyl 2,4-diF-Ph 4-Et-Ph 3-(4-Cl-PhO)Ph 2-F-Ph 3-pyridyl 4-Cl-3-pyrazolyl 2-Br-3-thienyl TABLE 39 Compounds of Formula Is wherein: 3-(R 28 N(Me)) Ph - (R 28 N (Me) ) 2-F-Ph -(R 28 N(Me)) 4-(4-Cl-PhO)Ph -(R 28 N(Me)) 3-pyridyl -(R 28 N(Me) ) 4-Me-2-pyrimidyl -(R 28 N(Me) ) 2-F-3-thienyl -(R 28 N(Me) ) 2-EtS-3-furanyl 3-(R 28 N(Me)) 4-N0 2 -2-oxazolyl 3-(R 28 N(Me) ) 5-Cl-3-isoxazolyl -(R 28 N(Me) ) 3-pyrazolyl (Z)-3-(R 28 CH=CH) 4-PhO-Ph -(R 28 CH=CH) 4-CF 3 -Ph (Z) -3- (R 28 CH=CH) 3-isoxazolyl 3-(R 28 OC(=0) ) 4-CF 3 -Ph 3-(R 28 0C(=0)) 2-Cl-5-pyrimidyl 3-(R 28 OC(=0)) 5-Me-2-furanyl 3-(R 28 0C(=S)) 5-N0 2 -3-isoxazolyl 3-(R 28 C(=0)0) 4-(4-butyl)Ph 3-(R 28 C(=S)0) 2-oxazolyl 3-(R 28 NHC(=S)0) 4-EtS-3-pyrazolyl 3-(R 28 OC(=S)0) 2,5-diF-3-thienyl 3- (R 28 N (Me) C (=0) O) 4-N0 2 -Ph E 59 3-(R 59 0CH 2 ) 3-thienyl 3-(R 59 CH 2 0) 5-F-2-oxazolyl 3-(R 59 (CH 2 ) 4 ) 4-pyrazolyl 3-(2-Cl-Ph) TABLE 39 Compounds of Formula I wherein W=0, R x =Me, R 3 =Ph, R =H, and: ,26 5-R 26 -3-F-2-furanyl 2-F-PhO 5-R 26 -3-F-2-furanyl 3-Br-PhO 5-R 26 -3-F-2-furanyl 2-Me-PhO 5-R 26 -3-F-2-furanyl 4-Et-PhO 5-R 26 -3-F-2-furanyl 2-MeO-PhO 5-R 26 -3-F-2-furanyl 4-EtO-PhO 5-R 26 -3-F-4-Cl-2-furanyl 2-F-PhO 5-R 26 -3-F-4-Cl-2-furanyl 4-Me-PhO 5-R 26 -4-CF 3 -2-furanyl 3-EtO-PhO 5-R 26 -4-Me-2-furanyl 4-Cl-PhO 5-R 26 -4-Et0-2-furanyl 3-Me-PhO 4-R 26 -3-F-2-furanyl 2-F-PhO 4-R 26 -3-F-2-furanyl 4-Cl-PhO 4-R 26 -5-Cl-2-furanyl 4-Et-PhO 4-R 26 -3-F-2-furanyl (2-Me-Ph)CH 2 0 4-R 26 -5-Me-2-furanyl (4-MeO-Ph)CH 2 0 5-R 26 -3-F-2-furanyl (2-F-Ph)CH 2 0 5-R 26 -3-F-2-furanyl (4-Et-Ph)CH 2 0 5-R 26 -2-F-3-furanyl 4-F-PhO 5-R 26 -2-F-3-furanyl 3-Cl-PhO 5-R 26 -2-F-3-furanyl 2-Me-PhO 5-R 26 -4-F-3-furanyl 3-Br-PhO 5-R 26 -2-F-3-furanyl (4-Br-Ph)CH 2 0 5-R 26 -2-F-3-furanyl (2-Me-Ph)CH 2 0 5-R 26 -4-F-3-furanyl (4-Et-Ph)CH 2 0 3-F-4-Me-2-furanyl 3-F-5-C 6 H 13 -2-furanyl 3-F-4-MeO-2-furanyl 4,5-diMe-3-F-2-furanyl 4-EtO-3-F-5-MeO-2-furanyl 5-EtO-4-Cl-2-furanyl 2-F-5-Me-3-furanyl 2-F-5-MeO-3-furanyl 5-Et-4-F-3-furanyl 2,4-diF-5-Me-3-furanyl Iv R 28 CH=CH 2-(4-MeO-PhO)-5- R 59 CH 2 0 3-MeO-Ph pyrimidyl R 59 CH 2 0 4-BuO-Ph R 59 (CH 2 ) 2 0 3-F-Ph E 50 E' 59 R 59 (CH 2 ) 2 0 2-Me-Ph R 59 (CH 2 ) 2 0 3-MeO-Ph R 59 (CH 2 ) 3 0 2-F-Ph R 59 (CH 2 ) 3 0 3-Me-Ph R 59 (CH 2 ) 3 0 4-BuO-Ph R 59 (CH 2 ) 4 0 2-MeO-Ph R 59 (CH 2 ) 4 0 3-F-Ph R 59 (CH 2 ) 4 0 4-Cl-Ph R 59 0CH 2 2-Cl-Ph R 59 OCH 2 4-Cl-Ph R 59 OCH 2 3-Br-Ph R 59 OCH 2 2,4-diF-Ph R 59 OCH 2 2-Cl-Ph R 59 OCH 2 4-CF 3 -Ph R 59 OCH 2 3-MeSrPh R 59 OCH 2 4-N0 2 -Ph R 59 OCH 2 2-Me-Ph R 59 OCH 2 4-Bu-Ph R 59 OCH 2 2-MeO-Ph .59 'OCH 2 3-(CH 3 CH(CH 3 )CH 2 0)' Ph R 59 0(CH 2 ) 2 2-Cl-Ph R 59 0(CH 2 ) 2 3-CF 3 -Ph R 59 0(CH 2 ) 2 3-MeO-Ph R 59 0(CH 2 ) 2 4-BuO-Ph R 59 0(CH 2 ) 2 4-Bu-Ph R 59 0(CH 2 ) 2 2-F-Ph R 59 0(CH 2 ) 3 2,4-diF-Ph R 59 0(CH 2 ) 3 4-Cl-Ph R 59 0(CH 2 ) 4 2-Me-Ph R 59 0(CH 2 ) 4 4-BuO-Ph Formulation/utility Compounds of this invention will generally be used in formulation with an agriculturally suitable composition. The fungicidal compositions of the present invention comprise an effective amount of at least one compound of Formula I as defined above and at least one of (a) a surfactant, (b) an organic solvent, and (c) at least one solid or liquid diluent. Useful formulations can be prepared in conventional ways. They include dusts, granules, pellets, solutions, suspensions, emulsions, wettable powders, emulsifiable concentrates, dry flowables and the like. Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High strength compositions are primarily used as intermediates for further formulation. The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges which add up 100 weight percent. Weight Percent Typical solid diluents are described in Watkins, et al. r Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey. Typical liquid diluents and solvents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950. McCutcheon ' s Detergents and Emulsifiers Annual, Allured Publ. Corp., Ridgewood, New Jersey, as well as Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964, list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth, etc. Methods for formulating such compositions are well known. Solutions are prepared by simply mixing the ingredients. Fine solid compositions are made by blending and, usually, grinding as in a hammer mill or fluid energy mill. Water-dispersible granules can be produced be agglomerating a fine powder composition," see for example, Cross et al. , Pesticide Formulations, Washington, D.C., 1988, pp 251-259. Suspensions are prepared by wet-milling; see, for example, U.S. 3,060,084. Granules and pellets can be made by spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, "Agglomeration", Chemical Engineering, December 4, 1967, pp 147-148, Perry 's Chemical Engineer 's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pp 8-57 and following, and WO 91/13546. Pellets can be prepared as described in U.S. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in DE 3,246,493. For further information regarding the art of formulation, see U.S. 3,235,361, Col. 6, line 16 through Col. 7, line 19 and Examples 10 through 41; U.S. 3,309,192, Col. 5, line 43 through Col. 7, line 62 and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182; U.S. 2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp 81-96; and Hance et al. , Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989. In the following Examples, all percentages are by weight and all formulations are worked up in conventional ways. Compound numbers refer to Index Table A hereinafter. Example A Wettable Powder Compound 1 65.0% dodecylphenol polyethylene glycol ether 2.0% sodium ligninsulfonate 4.0% sodium silicoaluminate 6.0% montmorillonite (calcined) 23.0%. E ample B Granule Compound 1 10.0% attapulgite granules (low volative matter, 0.71/0.30 mm; U.S.S. No. 25-50 sieves) 90.0%. Example C Extruded Pellet Compound 1 25.0% anhydrous sodium sulfate 10.0% crude calcium ligninsulfonate 5.0% sodium alk lnaphthalenesulfonate 1.0% calcium/magnesium bentonite 59.0%. Example D Emulsifiable Concentrate Compound 1 20.0% blend of oil soluble sulfonates and pol oxyeth lene ethers 10.0% isophorone 70.0%. The compounds of this invention are useful as plant disease control agents. The present invention therefore further comprises a method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof to be protected, or to the plant seed or seedling to be protected, an effective amount of a compound of Formula I or a fungicidal composition containing said compound. The compounds and compositions of this invention provide control of diseases caused by a broad spectrum of fungal plant pathogens in the Basidiomycete, Ascomycete, Oomycete and Deuteromycete classes. They are effective in controlling a broad spectrum of plant diseases, particularly foliar pathogens of ornamental, vegetable, field, cereal, and fruit crops. These pathogens include Plasmopara viticola, Phytophthora infestans, Peronospora tabacina, Pseudoperonospora cubensis, Pythium aphanidermatum, Alternaria brassicae, Septoria nodorum, Cercosporidium personatum, Cercospora arachidicola r Pseudocercosporella herpotrichoides, Cercospora beticola, Botrytis cinerea r Monilinia fructicola, Pyricularia oryzae, Podosphaera leucotricha r Venturia inaequalis r Erysiphe graminis, Uncinula necatur, Pυccinia recondita, Puccinia graminis, Hemileia vastatrix, Puccinia striiformis r Puccinia arachidis, Rhizoctonia solani, Sphaerotheca fuliginea, Fusarium oxysporum, Verticillium dahliae r Pythium aphanidermatum r Phytophthora megasperma and other generea and species closely related to these pathogens. Compounds of this invention can also be mixed with one or more other insecticides, fungicides, nematocides, bactericides, acaricides, semiochemicals, repellants, attractants, pheromones, feeding stimulants or other biologically active compounds to form a multi- component pesticide giving an even broader spectrum of agricultural protection. Examples of other agricultural protectants with which compounds of this invention can be formulated are: insecticides such as monocrotophos, carbofuran, tetrachlorvinphos, malathion, parathion—methyl, methomyl, chlordimeform, diazinon, deltamethrin, oxa yl, fenvalerate, esfenvalerate, permethrin, profenofos, sulprofos, triflumuron, diflubenzuron, methoprene, buprofezin, thiodicarb, acephate, azinphosmethyl, chlorpyrifos, dimethoate, fipronil, flufenprox, fonophos, isofenphos, methidathion, methamidophos, phosmet, phosphamidon, phosalone, pirimicarb, phorate, terbufos, trichlorfon, methoxychlor, bifenthrin, biphenate, cyfluthrin, fenpropathrin, fluvalinate, flucythrinate, tralomethrin, metaldehyde and rotenone; fungicides such as carbendazim, thiuram r dodine, maneb, chloroneb, benomyl, cymoxanil, fenpropidine, fenpropimorph, triadimefon, captan, thiophanate-methyl, thiabendazole, phosethyl-Al, chlorothalonil, dichloran, metalaxyl, captafol, iprodione, oxadixyl, vinclozolin, kasugamycin, m clobutanil, tebuconazole, difenoconazole, diniconazole, fluquinconazole, ipconazole, metconazole, penconazole, propiconazole, uniconzole, flutriafol, prochloraz, pyrifenox, fenarimol, triadimenol, diclobutrazol, copper ox chloride, furalaxyl, folpet, flusilazol, blasticidin S, diclomezine, edifenphos, isoprothiolane, iprobenfos, mepronil, neo-asozin, pencycuron, probenazole, pyroquilon r tricyclazole, validamycin, and flutolanil; nematocides such as aldoxycarb, fenamiphos and fosthietan; bactericides such as oxytetracyline, streptomycin and tribasic copper sulfate; acaricides such as binapacryl, oxythioquinox, chlorobenzilate, dicofol, dienochlor, cyhexatin, hexythiazox, amitraz, propargite, tebufenpyrad and fenbutatin oxide; and biological agents such as Bacillus thuringiensis, baculovirus and avermectin B. In certain instances, combinations with other fungicides having a similiar spectrum of control but a different mode of action will be particularly advantageous for resistance management. Plant disease control is ordinarily accomplished by applying an effective amount of a compound of this invention either pre— or post—infection, to the portion of the plant to be protected such as the roots, stems, foliage, fruit, seeds, tubers or bulbs, or to the media (soil or sand) in which the plants to be protected are growing. The compounds can also be applied to the seed to protect the seed and seedling. Rates of application for these compounds can be influenced by many factors of the environment and should be determined under actual use conditions. Foliage can normally be protected when treated at a rate of from less than 1 g/ha to 5,000 g/ha of active ingredient. Seed and seedlings can normally be protected when seed is treated at a rate of from 0.1 to 10 g per kilogram of seed. The following Tests demonstrate the control efficacy of compounds of this invention on specific pathogens. The pathogen control protection afforded by the compounds is not limited, however, to these species. See Index Table A for compound descriptions. Test compounds were first dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem® 014 (polyhydric alcohol esters) . The resulting test suspensions were then used in the following tests. TEST A The test suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings were inoculated with a spore suspension of Puccinia recondita (the causal agent of wheat leaf rust) and incubated in a saturated atmosphere at 20°C for 24 h, and then moved to a growth chamber at 20°C for 6 days, after which disease ratings were made. TEST B The test suspension was sprayed to the point of run-off on rice seedlings . The following day the seedlings were inoculated with a spore suspension of Pyricularia oryzae (the causal agent of rice blast) and incubated in a saturated atmosphere at 27°C for 24 h, and then moved to a growth chamber at 30°C for 5 days, after which disease ratings were made. TEST C The test suspension was sprayed to the point of run-off on tomato seedlings. The following day the seedlings were inoculated with a spore suspension of Phytophthora infestans (the causal agent of potato and tomato late blight) and incubated in a saturated atmosphere at 20°C for 24 h, and then moved to a growth chamber at 20°C for 5 days, after which disease ratings were made. TEST D The test suspension was sprayed to the point of run-off on potato seedlings . The following day the seedlings were inoculated with a spore suspension of Phytophthora infestans (the causal agent of potato and potato late blight) and incubated in a saturated atmosphere at 20°C for 24 h and then moved to a growth chamber at 20°C for 5 days, after which disease ratings were made. TEST E The test suspension was sprayed to the point of run-off on grape seedlings . The following day the seedlings were inoculated with a spore suspension of Plasmopara viticola (the causal agent of grape- downy mildew) and incubated in a saturated atmosphere at 20°C for 24 h, moved to a growth chamber at 20°C for 6 days, and then incubated in a saturated atmosphere at 20°C for 24 h, after which disease ratings were made. Index Table 1 Compounds of Formula I wherein: Cmpd Eo__. E 1 E 2 1 Me 2-F-6-PhO-3-pyridyl 2 Me 2,6-diF-3-pyridyl 3 Me 2-F-6-PhO-3-pyridyl 4 Me 2,6-diF-3-pyridyl 5 Me PhOCH 2 CH 2 CH 2 6 Me (E)-PhOCH 2 CH=CHCH 2 7 Me 2-F-6-(2-Cl-PhO)-3-pyridyl 8 Me 2-F-6-(2-Cl-PhO)-3-pyridyl 9 Me 2-F-6-(2-F-PhO)-3-pyridyl 10 Me 2-F-6- (2-F-PhO)-3-pyridyl 11 Me (2-F-PhO)CH 2 CH 2 CH 2 12 Me (2-Me-PhO)CH 2 CH 2 CH 2 13 Me 2-F-6-(2-Me-PhO)-3-pyridyl 14 Me (4-PhO-PhO)CH 2 CH 2 CH 2 15 Me 2-F-6-(2,3-diF-PhO)-3-pyridyl 16 Me 2-F-6-(2,3-diCl-PhO)-3-pyridyl 17 Me 2-F-6-(2-pyridylthio)-3-pyridyl 18 Me 2-F-6-(3-PhO-PhO)-3-pyridyl 19 Me 2-F-6-(2-MeO-PhO)-3-pyridyl 20 Me 3-(PhCH 2 CH 2 CH 2 0)Ph 21 Me PhO(CH 2 ) 4 22 Me 2-F-6-PhCH 2 0-3-pyridyl 23 H PhOCH 2 CH 2 CH 2 24 Me CH 3 (CH 2 ) 8 CH 2 25 Me CH 3 (CH 2 ) 6 CH 2 26 Me 4-(5-CF 3 -2-pyridyloxy)Ph 27 Me 4-(3-Cl-5-CF 3 -2-pyridyloxy)Ph 28 Me 4-(3-Cl-5-CF 3 -2-pyridyloxy)Ph 29 Me 4-[PhC(=0)0]Ph E 3 E 4 J_ mp CCl 1 Ph H O oil Ph H O 69 Ph H O 141 1 1-H NMR data for oils listed in Index Table 2 Index Table 2 C pd NO, 1 H NMR Data 1 26 6.43 (s, IH) , 6.76 (d, J=7.6, 2H) , 7.94 (d, J=8.6, IH) , 8.44 (s, IH) 39 2.05 (s, 3H) , 2.32 (s, 3H) , 6.04 (s, IH, NH) 47 3.38 (s, 3H) , 5.29 (s, 2H) , 6.08 (s, IH, NH) 49 3.36 (s, 3H) , 5.28 (s, 2H) , 6.34 (s, IH, NH) 62 1.67 (s, 3H) , 2.10-2.60 (m, 4H) , 4.58 (d, J=4, 2H) , 5.22-5.35 (m, 2H) , 5.95 (m, IH) , 6.26 (s, IH), 6.66 (t, J=4, IH) , 6.80-7.28 (m, 5H) . 1 Unless indicated otherwise, spectra were obtained in CDC1 3 at 400 MHz. s = singlet, d = doublet, m = multiplet, coupling constants (J) are in Hertz. Results for Tests A to E are given in Table 1. In the table, a rating of 100 indicates 100% disease control and a rating of 0 indicates no disease control (relative to the carrier sprayed controls) . NT indicates that no test was performed. TABLE 1 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 80 0 24 41 86 0 24 42 41 0 24 43 86 0 24 44 93 24 76 45 93 0 76 46 97 48 63 * = Plants were sprayed at a concentration of 40 ppm.

Claims: C A MS. We Claim: 1. A compound comprising Formula I wherei : R 1 is H; C x -C 4 alkyl; C x -C 4 haloalkyl; C 3 -C 6 cycloalkyl; C 2 -C 4 alkenyl; C 2 -C 4 alkox carbonyl; or phenylmethyl optionally substituted on the phenyl ring with R 6 and on the benzylic carbon with R 7 ; R 2 is C7~C 20 alkyl; C 7 -C 2 o haloalkyl; C 4 -C 17 alkyl substituted with C 3 -C 6 cycloalkyl; C -C 12 alkyl substituted with phenyl optionally substituted with R 31 on the phenyl ring; C 3 -C 14 alkyl substituted with phenoxy or phenylthio each optionally substituted with R 31 ; C 1 -C 20 alkyl substituted with R 19 ; C 2 -C 6 alkoxyalkyl substituted with R 21 ; C 7 -C 0 alkoxyalkyl optionally substituted with R 21 ; C 7 -C 20 alkenyl; C 2 -C 20 alkenyl substituted with R 20 ; C 7 - ' C 20 alkynyl; C -C 20 alkynyl substituted with R 48 ; C 5 -C 7 cycloalkenyl; (CH 2 CH 2 OCH 2 CH 2 )CH-; (CH 2 CH 2 (R 15 )CH 2 CH 2 )CH-; (CH 2 CH 2 SCH 2 CH 2 )CH-; (CH 2 CH 2 S0 2 CH 2 CH )CH-; pyrimidyl, pyrazinyl, pyridazinyl, oxazolyl, isoxazolyl, isothiazolyl or thiazolyl each optionally substituted with R 26 and R 18 ; furanyl substituted with one substituent selected from R 26 and one from R 18 ; pyridyl substituted with one substituent selected from R 49 , or one group from R 50 and one from R 18 ; or -T-Z; R 3 is phenyl, pyridyl, pyrimidinyl or pyridazyl each optionally substituted with R 10 ; or phenylmethyl; R 4 is H, methyl, or acetyl; R 5 , R 7 , R 11 , R 14 , R 23 , R 24 , R 30 , R 39 , R 43 , and R 55 are each independently H or C j^ -C, } alkyl; R 6 , R 29 , R 34 , R 38 , R 42 , R 44 , and R 56 are each independently 1-2 halogen; Cι~C alkyl; C ! -C alkoxy; trifluoromethyl; methylthio; or nitro; R 8 is C -C 19 alkyl; C 2 -C 19 alkylcarbonyl; C 2 -C 19 alkoxycarbonyl; (R 9 R 1 N)C=0; phenyl optionally substituted with R 27 ; or phenoxycarbonyl optionally substituted with R 17 ; R 9 is Ci-Cj ^ g alkyl; or phenyl optionally substituted with R 17 ; R 10 , R 27 , and R 45 are each independently 1-2 substituents selected from the group consisting of trifluoromethyl, trifluoromethoxy, nitro, C0 2 CH 3 , halogen, C 1 -C alkyl, C 1 -C 4 alkoxy, and cyano; R 12 is H; C- - Q alkyl optionally substituted with C 2 -C 7 alkoxycarbonyl; C 3 -C 8 alkenyl; phenylmethyl optionally substituted on the phenyl ring with R 34 and on the benzylic carbon with R 5 ; phenyl optionally substituted with R 34 ; or pyridyl optionally substituted with R 34 ; or R 11 and R 58 can be taken together as -CH 2 (CH 2 ) 2 CH 2 -, —CH 2 (CH 2 ) CH 2 ~,—CH (CH 2 ) CH 2 —, —CH CH 2 OCH 2 CH 2 —, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 N(R 5 )CH 2 CH 2 - or -CH 2 CH 2 N(R 5 )CH 2 CH 2 CH 2 - along with the nitrogen to which they are attached to form a ring; R 13 is Ci-Cg alkyl; C 3 -C 6 cycloalkyl; phenyl optionally substituted with R 45 ; or phenylmethyl optionally substituted on the phenyl ring with R 34 and on the benzylic carbon with R 5 ; R 15 is C x -C 12 alkyl; C 2 -C 12 alkylcarbonyl; benzoyl optionally substituted with R 16 on the phenyl ring; C 2 -C 12 alkoxycarbonyl; C 2 -C 12 alkylamino- carbonyl substituted with R 55 on nitrogen; phenoxycarbonyl optionally substituted with R 46 on the phenyl ring; or phenylaminocarbonyl optionally substituted with R 46 on the phenyl ring and with R 55 on nitrogen; R 16 is 3 halogen; cyano; C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; C-L-CS haloalkoxy; C 1 -C 8 alkylsulfonyl; C 2 -C 8 alkoxyalkyl; C -C 8 alkoxyalkoxy; C 2 -C 8 alkylthio; C 2 -C 8 alkenyl; C 2 -C 8 haloalkenyl; C 2 -C 8 alkynyl; hydroxycarbonyl; C 2 -C 8 alkoxy-carbonyl; or phenoxy substituted with R 29 ; R 17 , R 18 , R 32 , R 35 , R 47 , and R 53 are each independently 1-2 halogen; C 1 -C 2 alkyl; trifluoromethyl; or C 1 -C 2 alkoxy; R 19 is cyano; nitro; C^C^ alkylthio; C^C^ alkylsulfinyl; Cx-C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 19 alkenyloxy; C 3 -C 19 alkynyloxy; C j^ -C^ ^ g alkylsulfonyl; C -C 19 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC(=0)0; R 8 R 43 N; (C 1 -C 4 alkoxy) 2 P(=E)0; R 33 S0 3 ; R 43 R 14 R 23 N+; phenylsulfonyl, phenyl-sulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetra¬ hydropyranyl; 2-tetrahydropyranyloxy; or C(=J)R 24 ; R 20 is cyano; nitro; Cx-C^ alkylthio; C^C-^ alkylsulfinyl; C^C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 3 -C 17 haloalkynyl; C 3 -C 17 alkynyloxy; Cχ-C - 7 alkylsulfonyl; C -C 17 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(-0)0; R 22 R 43 NC(=0)0; R 8 R 3 N; (C J. -C 4 alkoxy) 2 P (=E)O; R 33 S0 3 ; R 43 R 1 R 23 N+; phenyl-sulfonyl, phenylsulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranyloxy; Cx-C^ alkoxy; 1-3 halogen; C 2 -C 17 alkoxy-alkoxy; C 3 -C 17 alkynyl; C 3 -C 6 cycloalkyl; or phenyl or phenoxy each optionally substituted with R 31 ; R 21 is cyano; nitro; C^C^ alkylthio; Cx-C^ alkylsulfinyl; C 1 -C 17 haloalkoxy; C 5 -Cg cycloalkyloxy; C 2 -C 17 haloalkenyl; C 3 -C 17 alkenyloxy; C 3 -C 17 haloalkynyl; C 3 -C 17 alkynyloxy; C;L-C 17 alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC (=0)O; R 8 R 43 N; (Cχ-C 4 alkoxy) 2 P(=E)0; R 33 S0 3 ; R 43 R 1 R 23 N+; phenylsulfonyl, phenylsulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranyloxy; C-i-C-π alkoxy; C 2 -C 17 alkoxyalkoxy; C 3 -C 17 alkynyl; C 3 -C 6 cycloalkyl; phenyl or phenoxy each optionally substituted with R 31 ; or C -C 17 haloalkoxyalkoxy; R 22 is Cx-Cxg alkyl; phenyl optionally substituted with R 36 ; or pyridyl optionally substituted with R 36 ; R 25 is H; Cx-C alkyl; or phenyl optionally substituted with R 35 ; R 26 is Cχ-Cg alkyl; Cχ-Cg alkoxy; phenoxy substituted with R 53 , or benzyloxy substituted on the phenyl ring with R 53 ; R28 j_ s phen l, pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, isoxazolyl, oxazolyl or pyrazolyl each optionally substituted with R 38 ; R 3l r R 36 f R 37 r R 4i f R 46 are independently 1-2 substituents selected from the group consisting of trifluoromethyl, trifluoromethoxy, nitro, C0 2 CH 3 , halogen, Cχ-C alkyl, C x -C 4 alkoxy, and cyano; or phenoxy substituted with R 44 ; R 33 is Cχ-Cg alkyl; or phenyl optionally substituted with R 32 ; R 40 is pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, pyrazolyl, naphthalenyl, isothiazolyl, thiazolyl, i idazolyl, oxazolyl, or isoxazolyl each optionally substituted with R 38 ; 2-tetra- hydropyranyl; or 2-tetrahydrofuranyl; R 48 is cyano; nitro; C- -Ci-j alkylthio; C^-C^ alkylsulfinyl; Cx-C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 3 -C 17 alkynyloxy; • Cχ-C 17 alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC(=0)0; R 8 R 43 N; (C ! -C 4 alkoxy) 2 P(=E)0; R 33 S0 3 ; R 43 R 14 R 23 N+; phenylsulfonyl, phenylsulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranyloxy; c i -c l7 alkoxy; 1-3 halogen; C 2 -C 17 alkoxyalkoxy; C 3 -C 6 cycloalkyl; or phenyl or phenoxy each optionally substituted with R 31 ; R 49 is C 5 -C 12 alkyl; C 2 -C 12 haloalkyl; C 5 -C 12 alkoxy; C -C 12 haloalkoxy; C 2 -C 12 alkylthio; C^C^ haloalkylthio; C 2 -C 12 alkenyl; C 2 -C 12 haloalkenyl; C 3 -C 12 alkynyl; C 2 -C 12 haloalkynyl; c 3 -c i 2 alkenyloxy; C 3 -C 12 haloalkenyloxy; C 3 -C 12 alkynyloxy; Cχ-C 12 alkylsulfonyl; Cχ-C 12 haloalkylsulfonyl; C 2 -C 12 alkoxyalkyl; C -C 1 alkoxyalkoxy; C 2 -C 12 alkoxycarbonyl; N(CH 3 ) 2 ; or G; R 50 is Cx-C alkyl; Cx-Cg haloalkyl; C -C 6 alkoxy; C -Cg haloalkoxy; Cx-C alkylthio; C -C haloalkylthio; C 2 -Cg alkenyl; C 2 -C 6 halo¬ alkenyl; C 3 -Cg alkynyl; C 2 -Cg haloalkynyl; C -Cg alkenyloxy; C 3 -C 6 haloalkenyloxy; C 3 -Cg alkynyloxy; C 3 -Cg cycloalkyl; C 3 -C 6 cyclo¬ alkyloxy; Cχ-Cg alkylsulfonyl; C -Cg halo¬ alkylsulfonyl; C -Cg alkoxyalkyl; C 2 -C 6 alkoxyalkoxy; C -Cg alkoxycarbonyl; N(CH 3 ) 2 ; or Y; R 51 is phenyl substituted with R 52 ; pyridyl or pyrimidyl each optionally substituted with R 37 ; .or thienyl, furanyl, isoxazolyl, oxazolyl, or pyrazolyl each optionally substituted with R 38 ; R52 1S 3 halogen; cyano; C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; Cχ-C 8 haloalkoxy; C 3 _-C 8 alkylsulfonyl; C 2 -C 8 alkoxyalkyl; C 2 -C 8 alkoxy¬ alkoxy; C 2 -C 8 alkylthio; C 5 -C 6 cycloalkyl; C 5 -C 6 cycloalkyloxy; C 2 -C 8 alkenyl; C 2 -C 8 halo¬ alkenyl; C 2 -C 8 alkynyl; hydroxycarbonyl; C 2 -C 8 alkoxycarbonyl; or phenoxy optionally substituted with R 29 ; R 54 is phenyl substituted with R 37 ; pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, isoxazolyl, oxazolyl, or pyrazolyl each optionally substituted with R 38 ; R 57 is Cχ-C 12 alkyl; C 3 -C 6 cycloalkyl; Cχ-C 12 haloalkyl; C 3 -C 12 alkenyl; C 3 -C 1 haloalkenyl; C 3 -C 12 alkynyl; C 3 -C 12 haloalkynyl; phenyl, naphthalenyl or pyridyl each optionally substituted with R 41 ; or furanyl or thienyl each optionally substituted with R 42 ; R 58 i s R l2 f c(=0)R 13 , C(=0)OR 13 or C(=0)NR 13 R 30 ; R 59 is phenyl optionally substituted with R 38 ; A is O, NR 25 , or a direct bond; E and V are independently 0 or S; G is -OR 51 ; -SR 51 ; -NHR 28 ; -N(CH 3 )R 28 ; -CH=CHR 28 (cis or trans); -C(=V)OR 28 ; -OC(=V)R 28 ; R 28 NR 39 C(=V)0-; -OC(=V)OR 28 ; -C(=V)NR 39 R 28 ; -(CH 2 ) m OR 59 ; -0(CH 2 ) m R59; _ {CH2 ) mR 59. Q r phenyl optionally substituted with R 38 ; J is 0 or N-A-L; L is H; Cχ-C 8 alkyl, C 3 -C 8 alkenyl; phenylmethyl optionally substituted with R 47 on the phenyl ring and R 55 on the benzylic carbon; phenyl optionally substituted with R 47 ; pyridyl optionally substituted with R 47 ; C(=0)R 22 ; C(=0)OR 22 ; or C(=0)NR 22 R 7 ; m is 1-4; n is 3-4; Q is 0, NR 11 , or a direct bond; T is phenyl optionally substituted with 1-2 halogen; Cχ-0 4 alkyl; Cχ-C 4 alkoxy; trifluoromethyl; methylthio; or nitro; W is 0, S, or N-Q-R 58 ; Y is -OR 28 ; -SR 28 ; -NHR 28 ; -N(CH 3 )R 28 ; -CH=CHR 28 (cis or trans); -C(=V)OR 28 ; -OC(=V)R 28 ; R 28 NR 39 C(=V)0-; -OC(=V)OR 28 ; -C (=V)NR 39 R 28 ; -(CH 2 ) m OR 59 ; -0(CH 2 ) m R 59 ; -(CH 2 ) m R 59 ; or phenyl optionally substituted with R 38 ; and Z is phenoxy substituted with R 16 ; C 3 -C 12 alkoxyalkoxyalkoxy; benzyloxymethoxy optionally substituted on the phenyl ring with R 56 ; C 5 -Cg cycloalkyloxy; styryl optionally substituted on the phenyl ring with R 41 ; -C(=V)OR 57 ; -OC(=V)R 57 ; -OC(=V)NR 39 R 57 ; -OC(=V)OR 57 ; -C(=V)NR 39 R 57 ; -(CH 2 ) n R 59 ; -(CH 2 ) n OR 59 ; -0(CH 2 ) n R 59 ; or -OR 40 ; and the agriculturally suitable salts thereof; provided that: i) when W is N-Q-R 58 , Z is other than phenoxy substituted with R 16 , C 5 -Cg cycloalkyloxy, or -C(=0) (C 1 -C 5 alkoxy); ii) when R 2 is an optionally substituted phenyl or heterocyclic ring, only H or F can be substituted on the carbon atom(s) of the phenyl or heterocyclic ring adjacent to the carbon bearing the oxazolidinone ring; iii) when two substituents are selected from the alkyl and alkoxy groups in R 10 , R 27 , R 31 , R 36 , R 37 , R 41 , R 45 or R 46 , then at least one of said substituents contains only one carbon atom; and iv) when R 2 is alkyl substituted with optionally substituted phenyl, then the phenyl group is not attached to the alkyl carbon attached to the oxazolidinone ring. 2. A compound of Claim 1, wherein R 1 is H; C -C 2 alkyl; or vinyl; R 2 is C 7 -C 20 alkyl; C7~C 20 haloalkyl; C 3 -C 8 alkyl substituted with phenoxy or phenylthio each optionally substituted with R 31 ; Cx-Cxg alkyl substituted with R 19 ; C 2 -C 6 alkoxyalkyl substituted with R 21 ; C 7 -C 16 alkoxyalkyl optionally substituted with R 21 ; C 7 -C 0 alkenyl; C 2 -C 16 alkenyl substituted with R 20 ; pyridyl substituted with one substituent selected from R 49 , or one group from R 50 and one from R 18 ; or -T-Z; R 3 is phenyl optionally substituted with C 1 -C 2 alkyl or halogen; R 4 is H or methyl; R 12 is C -C 8 alkyl; phenylmethyl; or phenyl; R 19 is C- L -Cx g alkylthio; Cχ-C 19 haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 19 alkenyloxy; C -C g alkylsulfonyl; C -C 19 alkoxycarbonyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC(=0)0; phenylsulfonyl, pyridyl or pyridyloxy each optionally substituted with ' R 31 ; thienyl or furanyl each optionally substituted with R 38 ; 2-tetrahydropyranyloxy; or CH(=N-A-L) ; R 20 is Cχ-Cχ- 7 alkylthio; C^C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C^C- j ^ alkylsulfonyl; C 2 -C 1 alkoxycarbonyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 3 NC(=0)0; phenylsulfonyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl or furanyl optionally substituted with R 38 ; 2-tetrahydropyranyloxy; C 1 -C 1 alkoxy; 1-3 halogen; C 3 -C 6 cycloalkyl; or phenyl or phenoxy each optionally substituted with R 31 ; R 21 is Cχ-Cχ- 7 alkylthio; C-L-C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C^-C^ alkyl¬ sulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxy¬ carbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC(=0)O; phenylsulfonyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl or furanyl each optionally substituted with R 38 ; 2-tetrahydropyranyloxy; C-i-C-n alkoxy; C 2 -C 17 alkoxyalkoxy; or phenyl or phenoxy each optionally substituted with R 31 ; R 28 is phenyl or pyridyl each optionally substituted with R 37 ; or thienyl or furanyl each optionally substituted with R 38 ; R 40 is pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl or furanyl each optionally substituted with R 38 ; 2-tetrahydropyranyl; or 2-tetrahydrofuranyl; R 51 is phenyl substituted with R 52 ; pyridyl optionally substituted with R 37 ; or thienyl or furanyl each optionally substituted with R 38 ; R 57 is C 1 -C 12 alkyl; C 3 -C 6 cycloalkyl; C 1 -C 12 haloalkyl; phenyl, naphthalenyl or pyridyl each optionally substituted with R 41 ; or furanyl or thienyl each optionally substituted with R 42 ; R 58 is R 12 ; A is 0 or NR 25 ; G is -OR 51 or -SR 51 ; L is H; C 1 -C 8 alkyl; phenylmethyl optionally substituted with R 47 on the phenyl ring; phenyl optionally substituted with R 47 ; or C(=0)R 22 ; Q is OH, NH, or a direct bond; Y is -OR 28 or -SR 28 ; and Z is phenoxy substituted with R 16 ; -C(=0)OR 57 ; -OC(=0)R 57 ; -OR 40 ; or -OC(=0)NHR 57 . provided that the total number of carbons in R 2 is less than or equal to 20; 3. A compound of Claim 2, wherein R 1 is methyl; R 2 is C 7 -C 20 alkyl; C 7 -C 20 haloalkyl; C 3 -C 8 alkyl substituted with phenoxy or phenylthio each optionally substituted with R 31 ; Cx-Cxg alkyl substituted with R 19 ; C 2 -C 6 alkoxyalkyl substituted with R 21 ; C 7 -C 16 alkoxyalkyl optionally substituted with R 21 ; C 7 -C 20 alkenyl; C 2 -C 16 alkenyl substituted with R 20 ; pyridyl substituted with one substituent selected from R 49 , or one group from R 50 and one from R 18 ; or -T-Z; R 3 is phenyl optionally substituted with F, Cl, or meth l; R 4 is H; R 16 is 3 halogen; C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; Cx-C β haloalkoxy; C 2 -C 8 alkylthio; C 2 -C 8 alkenyl; or phenoxy substituted with R 29 ; R 19 is C- L -Cx g alkylthio; Cx-C g haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 19 alkenyloxy; C 2 -C 19 alkoxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC(=0)0; pyridyl optionally substituted with R 31 ; or CH(=N-A-L) ; R 20 is C^C^ alkylthio; C^C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 2 -C 17 alkoxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC(=0)0; Cx-C^ alkoxy; 1-3 halogen; or phenyl or phenoxy each optionally substituted with R 31 ; R 21 is C χ -C χ - 7 alkylthio; Cx-C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 2 -C 17 alkoxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 3 NC(=0) 0; C 1 -C 17 alkoxy; C 2 -C 17 alkoxyalkoxy; or phenyl or phenoxy each optionally substituted with R 31 ; R 22 is Cx-Cx alkyl; or phenyl optionally substituted with R 36 ; R 28 is phenyl or pyridyl each optionally substituted with R 37 ; or thienyl optionally substituted with R 38 ; R 29 , R 38 , R 42 , and R 44 are independently 1-2 halogen selected from the group consisting of F and Cl; c ι~C 4 alkyl; or C^^ alkoxy; R 31 , R 36 , R 37 , and R 41 are independently trifluoromethyl; 1-2 halogen; cyano; C 1 -C 4 alkyl; C 1 -C alkoxy; or phenoxy substituted with R 44 ; R 40 is pyridyl substituted with R 37 ; or thienyl optionally substituted with R 38 ; R 49 is C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; C 2 -C 8 alkylthio; or thienyloxy optionally substituted with R 38 ; R 50 is Cx-Cg alkyl; Cx-Cg haloalkyl; Cx-C alkoxy; Cx-C haloalkoxy; Cx-C alkylthio; C -C 6 alkenyl; C 3 -C 6 alkenyloxy; C 3 -C 6 cycloalkyloxy; C -C 6 alkoxycarbonyl; or -OR 28 ; R 57 is C 1 -C 12 alkyl; phenyl or pyridyl optionally substituted with R4 1 ; or thienyl optionally substituted with R 42 ; A is O or NH; L is C 1 -C 8 alkyl; phenylmethyl; or phenyl; T is phenyl optionally substituted with 1-2 halogen selected from the group consisting of F and Cl, or C ] _-C 2 alkyl; W is 0 or S; and Z is phenoxy optionally substituted with R 16 ; -C(=0)0R 57 ; -OC(=0)R 57 ; -OR 40 ; or -OC(=0)NHR 57 . 4. A compound of Claim 3, wherein R 2 is C -C 12 alkyl; C 7 -C 12 haloalkyl comprised of fewer than 7 halogens from the group consisting of F and Cl; C 3 -C 8 alkyl substituted with phenoxy optionally substituted with R 31 ; C x -C 1 alkyl substituted with R 19 ; C 7 -C 12 alkoxyalkyl; C 7 -C 12 alkenyl; C 2 -C 12 alkenyl substituted with R 20 ; pyridyl substituted with one substituent selected from R 49 , or one group from R 50 and one from R 18 ; or -T-Z; R 18 is F, Cl, Br, or methoxy; R 19 is C-L-C 12 alkylthio; C 5 -C 6 cycloalkyloxy; pyridyloxy optionally substituted with R 31 ; or CH(=N-A-L) ; R 20 is C 1 -C 1 alkylthio; C 5 -C 6 cycloalkyloxy; C 1 -C 12 alkoxy; 1-3 halogen; phenyl or phenoxy each optionally substituted with R 31 ; R 31 , R 37 , and R 41 are 1-2 halogen selected from the group consisting of F and Cl; cyano, C- ~C alkyl, or C-i-C^ alkoxy; or phenoxy; R 38 is 1-2 halogen selected from the group consisting of F and Cl; methyl; or methoxy; R 49 is C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; or C -C 8 alkylthio; R 50 is C- L -Cg alkyl; C- L -Cg haloalkyl; C^-Cg alkoxy; c ι~ c 6 alkylthio; C 3 -C 6 cycloalkyloxy; or phenoxy optionally substituted with R 37 ; R 57 is C 1 -C 8 alkyl; or phenyl optionally substituted with R 41 ; L is C 1 -C 8 alkyl or phenylmethyl when A is O; or c ι~ c 8 alkyl or phenyl when A is NH; T is phenyl optionally substituted with fluorine or methyl; and Z is -OC(=0)R 57 or -OR 40 . 5. A compound of Claim 4, wherein R 2 is C 7 -C 12 alkyl; C 7 -C 12 haloalkyl; C 4 -C 6 alkyl substituted with phenoxy optionally substituted with R 31 ; C;L-C 12 alkyl substituted with R 19 ; C 7 -C 12 alkoxyalkyl; C 7 -C 12 alkenyl; pyridyl substituted with one group from R 50 and one halogen from the group consisting of F and Cl; or -T-Z; R 19 is C-L-C 19 alkylthio; C 5 -C 6 cycloalkyloxy; or pyridyloxy optionally substituted with ' R 31 ; R 50 is Cx-Cg alkyl; trifluoromethyl; Cx-Cg alkoxy; or phenoxy optionally substituted with R 37 ; and R 57 is C 2 -C 8 alkyl; or phenyl optionally substituted with R 41 . 6. A compound of Claim 5 comprising 5-methyl-5-octyl-3- (phenylamino) -2, - oxazolidinedione and the (S) -enantiomer thereof; 5- (2-fluoro-6-phenoxy-3-pyridinyl) -5-methyl- 3- (phenylamino) -2, 4-oxazolidinedione and the (S)-enantiomer thereof; 5-methyl-5- (3-phenoxypropyl) -3- (phenyl¬ amino) -2, 4-oxazolidinedione and the (S) -enantiomer thereof; 4-[5-methyl-2, 4-dioxo-3- (phenylamino) -5- oxazolidinyl]phenyl 3-chlorobenzoate and the (S) -enantiomer thereof; and 4-[5-methyl-2, 4-dioxo-3- (phenylamino) -5- oxazolidinyl]phenyl 4-cyanobenzoate and the (S) -enantiomer thereof. 7. A method of controlling fungal diseases in plants; comprising treating the locus to be protected with an effective amount of a compound of Formula I wherein R 1 is H; C 1 -C alkyl; C x -C 4 haloalkyl; C 3 -C 6 cycloalkyl; C -C 4 alkenyl; C 2 -C 4 alkoxy¬ carbonyl; or phenylmethyl optionally substituted on the phenyl ring with R 6 and on the benzylic carbon with R 7 ; R 2 is C 7 -C 20 alkyl; C 7 -C 20 haloalkyl; C 4 -C 17 alkyl substituted with C 3 -C 6 cycloalkyl; C 4 -C 12 alkyl substituted with phenyl optionally substituted with R 31 on the phenyl ring; C 3 -C 14 alkyl substituted with phenoxy or phenylthio each optionally substituted with R 31 ; C 1 -C 20 alkyl substituted with R 19 ; C 2 -C 6 alkoxyalkyl substituted with R 21 ; C 7 -C 20 alkoxyalkyl optionally substituted with R 21 ; C 7 -C 20 alkenyl; C 2 -C 20 alkenyl substituted with R 20 ; C 7 -C 20 alkynyl; C -C 0 alkynyl substituted with R 48 ; C 5 -C 7 cycloalkenyl; (CH 2 CH 2 OCH 2 CH 2 ) CH-; (CH 2 CH 2 N(R 15 )CH 2 CH 2 ) CH-; (CH 2 CH 2 SCH 2 CH 2 ) CH-; (CH 2 CH 2 S0 2 CH 2 CH 2 ) CH-; pyrimidyl, pyrazinyl, pyridazinyl, oxazolyl, isoxazolyl, isothiazolyl or thiazolyl each optionally substituted with R 26 and R 18 ; furanyl substituted with one substituent selected from R 26 and one from R 18 ; pyridyl substituted with one substituent selected from R 49 , or one group from R 50 and one from R 18 ; or -T-Z; R 3 is phenyl, pyridyl, pyrimidinyl or pyridazyl each optionally substituted with R 10 ; or phenylmethyl; R 4 is H, methyl, or acetyl; R 5 , R 7 , R 11 , R 14 , R 23 , R 24 , R 30 , R 39 , R 43 , and R 55 are each independently H or C ! -C alkyl; R 6 , R 29 , R 34 , R 38 , R 42 , R 44 , and R 56 are each independently 1-2 halogen; Cι-C 4 alkyl; C 1 -C alkoxy; trifluoromethyl; methylthio; or nitro; R 8 is Cx-Cxg alkyl; C 2 -C ιg alkylcarbonyl; C 2 -C 19 alkoxycarbonyl; (R 9 R 14 N)C=0; phenyl optionally substituted with R 27 ; or phenoxycarbonyl optionally substituted with R 17 ; R 9 is Cx-C^ alkyl; or phenyl optionally substituted with R 17 ; R 10 , R 27 , and R 45 are each independently 1-2 substituents selected from the group consisting of trifluoromethyl, trifluoromethoxy, nitro, C0 2 CH 3 , halogen, C 1 -C 4 alkyl, C 1 -C alkoxy, and cyano; R 12 is H; Cx-Cs alkyl optionally substituted with C 2 -C 7 alkoxycarbonyl; C 3 -C 8 alkenyl; phenylmethyl optionally substituted on the phenyl ring with R 34 and on the benzylic carbon with R 5 ; phenyl optionally substituted with R 34 ; or pyridyl optionally substituted with R 34 ; or R 11 and R 58 can be taken together as -CH 2 (CH 2 ) 2 CH 2 -, —CH 2 (CH 2 ) 3 CH 2 _ , —CH 2 (CH 2 ) 4 CH 2 —, —CH 2 CH 2 OCH 2 CH 2 —, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 N(R 5 )CH 2 CH 2 - or -CH 2 CH 2 N(R 5 )CH 2 CH 2 CH 2 - along with the nitrogen ' to which they are attached to form a ring; R 13 is C-L-Cg alkyl; C 3 -Cg cycloalkyl; phenyl optionally substituted with R 45 ; or phenylmethyl optionally substituted on the phenyl ring with R 34 and on the benzylic carbon with R 5 ; R 15 is C ! -C 12 alkyl; C 2 -C 1 alkylcarbonyl; benzoyl optionally substituted with R 16 on the phenyl ring; C 2 -C 12 alkoxycarbonyl; C 2 -C 12 alkylamino- carbonyl substituted with R 55 on nitrogen; phenoxycarbonyl optionally substituted with R 46 on the phenyl ring; or phenylaminocarbonyl optionally substituted with R 46 on the phenyl ring and with R 55 on nitrogen; R 16 is 3 halogen; cyano; C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; Cx-^ haloalkoxy; Cx-Ce alkylsulfonyl; C 2 -C 8 alkoxyalkyl; C 2 -C 8 alkoxyalkoxy; C 2 -C 8 alkylthio; C 2 -C 8 alkenyl; C 2 -C 8 haloalkenyl; C 2 -C 8 alkynyl; hydroxycarbonyl; C 2 -C 8 alkoxy-carbonyl; or phenoxy substituted with R 29 ; R 17 , R 18 , R 32 , R 35 , R 47 , and R 53 are each independently 1-2 halogen; C 1 -C 2 alkyl; trifluoromethyl; or C 1 -C 2 alkoxy; R 19 is cyano; nitro; Cx-C^ alkylthio; Cx-C^ alkylsulfinyl; C^C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 19 alkenyloxy; C 3 -C 19 alkynyloxy; C±-Cι~ alkylsulfonyl; C 2 -C 19 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC(=0)0; R 8 R 43 N; (C-ι-C 4 alkoxy) 2 P(=E)0; R 33 S0 3 ; R 3 R 14 R 23 N+; phenylsulfonyl, phenyl-sulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphtha-len loxy ' each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranyloxy; or C(=J)R 24 ; R20 i s cyano; nitro; C^C^ alkylthio; Cx-C^ alkylsulfinyl; Cx-C^ haloalkoxy; C 5 -Cg cycloalkyloxy; C 3 -C 17 alkenyloxy; C 3 -C 17 haloalkynyl; C 3 -C 17 alkynyloxy;. Cx-C^ alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 0C(=0)0; R 22 R 43 NC(=0)0; R 8 R 43 N; (Cx-Cή alkoxy) 2 P (=E)0; R 33 S0 3 ; R 3 R 14 R 23 N+; phenyl-sulfonyl, phenylsulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranyloxy; 0-^-0^ alkoxy; 1-3 halogen; C 2 -C 17 alkoxy-alkoxy; C 3 -C 17 alkynyl; C 3 -C 6 cycloalkyl; or phenyl or phenoxy each optionally substituted with R 31 ; R 21 is cyano; nitro; C T L-C 17 alkylthio; Cx-C^ alkylsulfinyl; C^C-^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 2 -C 17 haloalkenyl; C 3 -C 17 alkenyloxy; C 3 -C 17 haloalkynyl; C 3 -C 17 alkynyloxy; C^C^ alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC (=0)O; R 8 R 43 N; (Cx-d alkoxy) 2 P(=E)0; R 33 S0 3 ; R 43 R 1 R 23 N+; phenylsulfonyl, phenylsulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranyloxy; C -C^ alkoxy; C -C 17 alkoxyalkoxy; C 3 -C 17 alkynyl; C 3 -C 6 cycloalkyl; phenyl or phenoxy each optionally substituted with R 31 ; or C 2 -C 17 haloalkoxyalkoxy; R 22 is Cx-C alkyl; phenyl optionally substituted with R 36 ; or pyridyl optionally substituted with R 36 ; R 25 is H; Cx-C alkyl; or phenyl optionally substituted with R 35 ; R 26 is Cx-C alkyl; C^Cg alkoxy; phenoxy substituted with R 53 , or benzyloxy substituted on the phenyl ring with R 53 ; R 28 is phenyl, pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, isoxazolyl, oxazolyl or pyrazolyl each optionally substituted with R 38 ; R 31 , R 36 , R 37 , R 41 , R 46 are independently 1-2 substituents selected from the group consisting of trifluoromethyl, trifluoromethoxy, nitro, C0 2 CH 3 , halogen, C -C alkyl, C 1 -C 4 alkoxy, and cyano; or phenoxy substituted with R 44 ; R 33 is Cx-Cg alkyl; or phenyl optionally substituted with R 32 ; R 40 is pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, pyrazolyl, naphthalenyl, isothiazolyl, thiazolyl, imidazolyl, oxazolyl, or isoxazolyl each optionally substituted with R 38 ; 2-tetrahydropyranyl; or 2-tetrahydrofuranyl; R 48 is cyano; nitro; Cχ-Cχ- 7 alkylthio; C 1 -C 17 alkylsulfinyl; C -Cχ- 7 haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 3 -C 17 alkynyloxy; C-^-C-^η alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 0C(=0)0; R 22 R 43 NC(=0)0; R 8 R 43 N; (C -C 4 alkoxy) 2 P(=E)0; R 33 S0 3 ; R 43 R 14 R 23 N+; phenylsulfonyl, phenylsulfinyl, pyridyl or pyridyloxy each optionally substituted with ' R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranylbxy; c ι~ c i 7 alkoxy; 1-3 halogen; C 2 -C 17 alkoxyalkoxy; C 3 -C 6 cycloalkyl; or phenyl or phenoxy each optionally substituted with R 31 ; R 49 is C 5 -C 12 alkyl; C 2 -C 12 haloalkyl; C 5 -C 12 alkoxy; C 1 -C 12 haloalkoxy; C 2 -C 12 alkylthio; C 1 -C 12 haloalkylthio; C 2 -C 1 alkenyl; C 2 -C 12 haloalkenyl; C 3 -C 12 alkynyl; C 2 -C 12 haloalkynyl; C 3 -C 1 alkenyloxy; C 3 -C 12 haloalkenyloxy; C 3 -C 12 alkynyloxy; C 1 -C 12 alkylsulfonyl; C -C^ haloalkylsulfonyl; C -C 12 alkoxyalkyl; C 2 -C 12 alkoxyalkoxy; C 2 -C 12 alkoxycarbonyl; N(CH 3 ) 2 ; or G; R 50 is Cx-Cg alkyl; C- L -Cg haloalkyl; Cx-Cg alkoxy; Cx-Cg haloalkoxy; C^C alkylthio; C -C haloalkylthio; C 2 -C 6 alkenyl; C 2 -C 6 haloalkenyl; C 3 -C 6 alkynyl; C 2 -C 6 haloalkynyl; C 3 -C 6 alkenyloxy; C 3 -C 6 haloalkenyloxy; C 3 -C 6 alkynyloxy; C 3 -C 6 cycloalkyl; C 3 -C 6 cyclo¬ alkyloxy; C- -C - alkylsulfonyl; Cx-C halo¬ alkylsulfonyl; C 2 -C 6 alkoxyalkyl; C 2 -C 6 alkoxyalkoxy; C 2 -C 6 alkoxycarbonyl; N(CH 3 ) 2 ; or Y; R 51 is phenyl substituted with R 52 ; pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, isoxazolyl, oxazolyl, or pyrazolyl each optionally substituted with R 38 ; R 52 is 3 halogen; cyano; C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; C 1 -C 8 haloalkoxy; Cx-C β alkylsulfonyl; C -C 8 alkoxyalkyl; C 2 -C 8 alkoxyalkoxy; C -C 8 alkylthio; C 5 -C 6 cycloalkyl; C 5 -C 6 cycloalkyloxy; C 2 -C 8 alkenyl; C 2 -C 8 haloalkenyl; C 2 -C 8 alkynyl; hydroxycarbonyl; C 2 -C 8 alkoxycarbonyl; or phenoxy optionally substituted with R 29 ; R 54 is phenyl substituted with R 37 ; pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, isoxazolyl, oxazolyl, or pyrazolyl each optionally substituted with R 38 ; R 57 is C ! -C 12 alkyl; C 3 -C 6 cycloalkyl; C ! -C 12 haloalkyl; C 3 -C 12 alkenyl; C 3 -C 12 haloalkenyl; C 3 -C 12 alkynyl; C 3 -C 12 haloalkynyl; phenyl, naphthalenyl or pyridyl each optionally substituted with R 41 ; or furanyl or thienyl each optionally substituted with R 42 ; R 58 ig R 12 f C(=0)R 13 , C(=0)OR 13 or C (=0)NR 13 R 30 ; R 59 is phenyl optionally substituted with R 38 ; A is 0, NR 25 , or a direct bond; E and V are independently 0 or S; G is -OR 51 ; -SR 51 ; -NHR 28 ; -N(CH 3 )R 28 ; -CH=CHR 28 (cis or trans); -C(=V)OR 28 ; -OC(=V)R 28 ; R 2 8 NR 39 C <=V )0-; -OC (=V) OR 28 ; -C (=V)NR 39 R 28 ; -(CH 2 ) m OR 59 ; -0(CH 2 ) m R 59 ; -(CH 2 ) m R 59 ; or phenyl optionally substituted with R 38 ; J is 0 or N-A-L; L is H; C j^ -Cg alkyl, C 3 -C 8 alkenyl; phenylmethyl optionally substituted with R 47 on the phenyl ring and R 55 on the benzylic carbon; phenyl optionally substituted with R 47 ; pyridyl optionally substituted with R 47 ; C(=0)R 22 ; C(=0)OR 22 ; or C(=0)NR 22 R 7 ; m is 1-4; n is 3-4; Q is 0, NR 11 , or a direct bond; T is phenyl optionally substituted with 1-2 halogen; C 1 -C alkyl; C 1 -C 4 alkoxy; trifluoromethyl; methylthio; or nitro; is 0, S, or N-Q-R 58 ; Y is -OR 28 ; -SR 28 ; -NHR 28 ; -N(CH 3 )R 28 ; -CH=CHR 28 (cis or trans); -C(=V)OR 28 ; -OC(=V)R 28 ; R 28 NR 39 C(=V)0-; -OC(=V)OR 28 ; -C(=V)NR 39 R 28 ; -(CH 2 .) m OR 59 ; -0(CH 2 ) m R 59 ; -(CH 2 ) m R 59 ; or phenyl optionally substituted with R 38 ; and Z is phenoxy substituted with R 16 ; C 3 -C 12 alkoxyalkoxyalkoxy; benzylox methoxy optionally substituted on the phenyl ring with R 56 ; C 5 -C 6 cycloalkyloxy; styryl optionally substituted on the phenyl ring with R 41 ; -C(=V)OR 57 ; -0C(=V)R 57 ; -OC (=V)NR 39 R 57 ; -OC(=V)OR 57 ; -C(=V)NR 39 R 57 ; -(CH 2 ) n R 59 ; -(CH 2 ) n 0R 59 ; -0(CH 2 ) n R 59 ; or -OR 40 ; and the agriculturally suitable salts thereof; provided that: i) when is N-Q-R 58 , Z is other than phenoxy substituted with R 16 , C 5 -C 6 cycloalkyloxy, or -C(=0) (C^Cs alkoxy); ii) when R 2 is an optionally substituted phenyl or heterocyclic ring, only H or F can be substituted on the carbon atom(s) of the phenyl or heterocyclic ring adjacent to the carbon bearing the oxazolidinone ring; iii) when two substituents are selected from the alkyl and alkoxy groups in R 10 , R 27 , R 31 , R 36 , R 37 , R 41 , R 45 or R 46 , then at least one of said substituents contains only one carbon atom; and iv) when R 2 is alkyl substituted with optionally substituted phenyl, then the phenyl group is not substituted on the alkyl carbon attached to the oxazolidinone ring. 8. The method of Claim 7, wherein R 1 is H; C 1 -C 2 alkyl; or vinyl; R 2 is C 7 -C 20 alkyl; C7~C 20 haloalkyl; C 3 -C 8 alkyl substituted with phenoxy or phenylthio each optionally substituted with R 31 ; C^C^ alkyl substituted with R 19 ; C 2 -C 6 alkoxyalkyl substituted with R 21 ; C 7 -C 16 alkoxyalkyl optionally substituted with R 21 ; C 7 -C 20 alkenyl; C 2 -C 16 alkenyl substituted with R 20 ; pyridyl substituted with one substituent selected from R 49 , or one group from R 50 and one from R 18 ; or -T-Z; R 3 is phenyl optionally substituted with C 1 -C 2 alkyl or halogen; R 4 is H or methyl; R 12 is ^-^ alkyl; phenylmethyl; or phenyl; R 19 is C 1 -C ιg alkylthio; C^C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 19 alkenyloxy; C^C^ alkylsulfonyl; C 2 -C 19 alkoxycarbonyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC(=0)0; phenylsulfonyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl or furanyl each optionally substituted with R 38 ; 2-tetrahydropyranyloxy; or CH(=N-A-L); R 20 is C 1 -C 17 alkylthio; C 1 -C 17 haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 1 -C 17 alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC(=0)0; phenylsulfonyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl or furanyl optionally substituted with R 38 ; 2-tetrahydropyranyloxy; C 1 -C 17 alkoxy; 1-3 halogen; C 3 -C 6 cycloalkyl; or phenyl or phenoxy each optionally substituted with R 31 ; R 21 is C 1 -C 17 alkylthio; C- ^ -C^ haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 1 -C 17 alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 3 NC(=0)0; phenylsulfonyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl or furanyl each optionally substituted with R 38 ; 2-tetrahydropyranyloxy; C 1 -C 17 alkoxy; C 2 -C 17 alkoxyalkoxy; or phenyl or phenoxy each optionally substituted with R 31 ; R28 i s phenyl or pyridyl each optionally . substituted with R 37 ; or thienyl or furanyl each optionally substituted with R 38 ; R 40 is pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl or furanyl each optionally substituted with R 38 ; 2-tetrahydropyranyl; or 2-tetrahydrofuranyl; R 51 is phenyl substituted with R 52 ; pyridyl optionally substituted with R 37 ; or thienyl or furanyl each optionally substituted with R 38 ; R 57 is C ! -C 12 alkyl; C 3 -C 6 cycloalkyl; C L -C 12 haloalkyl; phenyl, naphthalenyl or pyridyl each optionally substituted with R 41 ; or furanyl or thienyl each optionally substituted with R 42 ; R 58 is R 12 ; A is O or NR 25 ; G is -OR 51 or -SR 51 ; L is H; Ci-Cg alkyl; phenylmethyl optionally substituted with R 47 on the phenyl ring; phenyl optionally substituted with R 47 ; or C(=0)R 22 ; Q is OH, NH, or a direct bond; Y is -OR 28 or -SR 28 ; and Z is phenoxy substituted with R 16 ; -C(=0)OR 57 ; -OC(=0)R 57 ; -OR 40 ; or -OC(=0)NHR 57 . provided that the total number of carbons in R2 is less than or equal to 20; 9. The method of Claim 7, wherein the fungal diseases are caused by the plant pathogens Phytophthora infestans, and Plasmopara viticola . 10. A fungicidal composition comprising at least one of (a) a surfactant, (b) an organic•solvent, and (c) at least one solid or liquid diluent, and an effective amount of a compound of Formula I wherein: R 1 is H; C x -C 4 alkyl; C 1 -C 4 haloalkyl; C 3 -C 6 . cycloalkyl; C -C 4 alkenyl; C -C alkoxycarbonyl; or phenylmethyl optionally substituted on the phenyl ring with R 6 and on the benzylic carbon with R 7 ; R 2 is C7-C 20 alkyl; C 7 -C 20 haloalkyl; C -C 17 alkyl substituted with C 3 -C 6 cycloalkyl; C -C 12 substituted with phenyl optionally substituted with R 31 on the phenyl ring; C 3 -C 1 alkyl substituted with phenoxy or phenylthio each optionally substituted with R 31 ; C 1 -C 20 alkyl substituted with R 19 ; C 2 -Cg alkoxyalkyl substituted with R 21 ; C 7 -C 0 alkoxyalkyl optionally substituted with R 21 ; C 7 -C 2(J alkenyl; C 2 -C 20 alkenyl substituted with R 20 ; C 7 -C 20 alkynyl; C 2 -C 0 alkynyl substituted with R 48 ; C 5 -C 7 cycloalkenyl; (CH 2 CH 2 OCH 2 CH 2 ) CH-; (CH 2 CH 2 N(R 15 ) CH 2 CH 2 ) CH-; (CH 2 CH 2 SCH 2 CH 2 )CH-; (CH 2 CH 2 S0 2 CH 2 CH 2 )CH-; pyrimidyl, pyrazinyl, pyridazinyl, oxazolyl, isoxazolyl, isothiazolyl or thiazolyl each optionally substituted with R 26 and R 18 ; furanyl substituted with one substituent selected from R 26 and one from R 18 ; pyridyl substituted with one substituent selected from R 49 , or one group from R 50 and one from R 18 ; or -T-Z; R 3 is phenyl, pyridyl, pyrimidinyl or pyridazyl each optionally substituted with R 10 ; or phenylmeth l; R 4 is H, methyl, or acetyl; R 5 , R 7 , R 11 , R 14 , R 23 , R 24 , R 30 , R 39 , R 43 , and R 55 are each independently H or C 1 -C 4 alkyl; R 6 , R 29 , R 34 , R 38 , R 42 , R 44 , and R 56 are each independently 1-2 halogen; Cχ-C alkyl; C 1 -C alkoxy; trifluoromethyl; methylthio; or nitro; R 8 is Ci-Cig alkyl; C 2 -C 19 alkylcarbonyl; C 2 -C 19 alkox carbonyl; (R 9 R 14 N) C=0; phenyl optionally • substituted with R 27 ; or phenoxycarbonyl optionally substituted with R 17 ; R 9 is C 1 -C 18 alkyl; or phenyl optionally substituted with R 17 ; R 10 , R 27 , and R 45 are each independently 1-2 substituents selected from the group consisting of trifluoromethyl, trifluoromethoxy, nitro, C0 2 CH 3 , halogen, C x -C 4 alkyl, C x -C alkoxy, and cyano; R 12 is H; C ] _-C 8 alkyl optionally substituted with C 2 -C 7 alkoxycarbonyl; C 3 -C 8 alkenyl; phenylmethyl optionally substituted on the phenyl ring with R 34 and on the benzylic carbon with R 5 ; phenyl optionally substituted with R 34 ; or pyridyl optionally substituted with R 34 ; or R 11 and R 58 can be taken together as rCH 2 (CH 2 ) CH 2 -, —CH 2 (CH 2 ) CH ~, —CH 2 (CH 2 ) 4 CH 2 —, —CH 2 CH 2 OCH 2 CH 2 —, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 (R 5 ) CH 2 CH 2 - or -CH 2 CH 2 N(R 5 )CH 2 CH 2 CH 2 - along with the nitrogen to which they are attached to form a ring; R 13 is C j^ -Cg alkyl; C 3 -C 6 cycloalkyl; phenyl optionally substituted with R 45 ; or phenylmethyl optionally substituted on the • phenyl ring with R 34 and on the benzylic carbon with R 5 ; R 15 is C 1 -C 12 alkyl; C -C 1 alkylcarbonyl; benzoyl optionally substituted with R 16 on the phenyl ring; C 2 -C 12 alkoxycarbonyl; C 2 -C 1 alkylamino- carbonyl substituted with R 55 on nitrogen; phenoxycarbonyl optionally substituted with R 46 on the phenyl ring; or phenylaminocarbonyl optionally substituted with R 46 on the phenyl ring and with R 55 on nitrogen; R 16 is 3 halogen; cyano; C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; C 1 -C 8 haloalkoxy; C 1 -C 8 alkylsulfonyl; C -C 8 alkoxyalkyl; C 2 -C 8 alkoxyalkoxy; C 2 -C 8 alkylthio; C -C 8 alkenyl; C -C 8 haloalkenyl; C 2 -C 8 alkynyl; hydroxycarbonyl; C 2 -C 8 alkoxy-carbonyl; or phenoxy substituted with R 29 ; R 17 , R 18 , R 32 , R 35 , R 47 , and R 53 are each independently 1-2 halogen; C 1 -C 2 alkyl; trifluoromethyl; or C x -C 2 alkoxy; R 19 is cyano; nitro; C 1 -C ιg alkylthio; C^C^ alkylsulfinyl; C 1 -C 1 g haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 19 alkenyloxy; C 3 -C 19 alkynyloxy; C 1 -C 19 alkylsulfonyl; C 2 -C 19 alkoxycarbonyl; hydroxyl; hydrox carbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 43 NC(=0)O; R 8 R 43 N; (C 1 -C 4 alkoxy) 2 P(=E)0; R 33 S0 3 ; R 43 R 14 R 23 N+; phenylsulfonyl, phenyl-sulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetra¬ hydrop ranyl; 2-tetrahydropyranyloxy; or C(=J)R 24 ; R 20 is cyano; nitro; C 1 -C 17 alkylthio; C^-C j ^ alkylsulfinyl; C 1 -C 17 haloalkoxy; C 5 -Cg cycloalkyloxy; C 3 -C 17 alkenyloxy; C 3 -C 17 haloalkynyl; C 3 -C 17 alkynyloxy; C 1 -C 17 alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; alkoxy) 2 P (=E)0; R 33 S0 3 ; R 43 R 1 R 23 N+; phenyl-sulfonyl, phenylsulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranyloxy; C^-C^ alkoxy; 1-3 halogen; C 2 -C 17 alkoxy-alkoxy; C 3 -C 17 alkynyl; C 3 -C 6 cycloalkyl; or phenyl or phenoxy each optionally substituted with R 31 ; R 21 is cyano; nitro; C 1 -C 17 alkylthio; C^C^ alkylsulfinyl; C 1 -C 17 haloalkoxy; C 5 -Cg cycloalkyloxy; C 2 -C 17 haloalkenyl; C 3 -C 17 alkenyloxy; C 3 -C 17 haloalkynyl; C 3 -C 17 alkynyloxy; C 1 -C 17 alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 0C(=0)0; R 22 R 3 NC (=0)0; R 8 R 3 N; (C^^ alkoxy) 2 P(=E)0; R 33 S0 3 ; R 43 R 14 R 23 N+; phenylsulfonyl, phenylsulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranyloxy; c ι -c i 7 alkoxy; C 2 -C 17 alkoxyalkoxy; C 3 -C 17 alkynyl; C 3 -C 6 cycloalkyl; phenyl or phenoxy each optionally substituted with R 31 ; or C 2 -C 17 haloalkoxyalkoxy; R 22 is C^C- L alkyl; phenyl optionally substituted with R 36 ; or pyridyl optionally substituted with R 36 ; R25 i s H; C^-C 8 alkyl; or phenyl optionally substituted with R 35 ; R 26 is Ci-C alkyl; ^-Cg alkoxy; phenoxy substituted with R 53 , or benzyloxy substituted on the phenyl ring with R 53 ; R 28 is phenyl, pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, isoxazolyl, oxazolyl or pyrazolyl each optionally substituted with R 38 ; R 31 , R 36 , R 37 , R 41 , R 46 are independently 1-2 substituents selected from the group consisting of trifluoromethyl, trifluoromethoxy, nitro, C0 CH 3 , halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, and cyano; or phenoxy substituted with R 44 ; R 33 is C^Cg alkyl; or phenyl optionally substituted with R 32 ; R 40 is pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, pyrazolyl, naphthalenyl, isothiazolyl, thiazolyl, imidazolyl, oxazolyl, or isoxazolyl each optionally substituted with R 38 ; 2-tetra¬ hydropyranyl; or 2-tetrahydrofuranyl; R 48 is cyano; nitro; C 1 -C 17 alkylthio; C 1 -C 17 alkylsulfinyl; C;ι_-C 17 haloalkoxy; C 5 -C 6 cycloalkyloxy; C 3 -C 17 alkenyloxy; C 3 -C 17 alkynyloxy; C^-C^ alkylsulfonyl; C 2 -C 17 alkoxycarbonyl; hydroxyl; hydroxycarbonyl; R 22 C(=0)0; R 22 OC(=0)0; R 22 R 3 NC(=0)O; R 8 R 43 N; (C 1 -0 4 alkoxy) 2 P (=E)0; R 33 S0 3 ; R 3 R 14 R 23 N+; phenylsulfonyl, phenylsulfinyl, pyridyl or pyridyloxy each optionally substituted with R 31 ; thienyl, pyrimidinyl, furanyl, naphthalenyl, pyrimidinyloxy, naphthalenyloxy each optionally substituted with R 38 ; tetrahydropyranyl; 2-tetrahydropyranyloxy; C 1 -C 17 alkoxy; 1-3 halogen; C -C 17 alkoxyalkoxy; C 3 -C 6 cycloalkyl; or phenyl or phenoxy each optionally substituted with R 31 ; R 49 is C 5 -C 12 alkyl; C 2 -C 12 haloalkyl; C 5 -C 12 alkoxy; ^ 1 _C 12 haloalkoxy; C 2 -C 12 alkylthio; Ci~C 12 haloalkylthio; C 2 -C 12 alkenyl; C 2 -C 12 haloalkenyl; C 3 -C 12 alkynyl; C 2 -C 12 haloalkynyl; C 3 -C 12 alkenyloxy; C 3 -C 12 haloalkenyloxy; C 3 -C 12 alkynyloxy; C 1 -C 12 alkylsulfonyl; C 1 -C 12 haloalkylsulfonyl; C 2 -C 12 alkoxyalkyl; C 2 -C 12 alkoxyalkoxy; C 2 -C 12 alkoxycarbonyl; N(CH 3 ) ; or G; R 50 is C j ^-Cg alkyl; C^Cg haloalkyl; C j^ -Cg alkoxy; C^-Cg haloalkoxy; Cx-Cg alkylthio; C^C haloalkylthio; C -C 6 alkenyl; C 2 -Cg halo¬ alkenyl; C 3 -Cg alkynyl; C -C 6 haloalkynyl; C 3 -Cg alkenyloxy; C 3 -C 6 haloalkenyloxy; C 3 -Cg alkynyloxy; C 3 -Cg cycloalkyl; C 3 -Cg cyclo¬ alkyloxy; C j^ -C alkylsulfonyl; C^Cg halo- alkylsulfonyl; C 2 -Cg alkoxyalkyl; C 2 -C 6 alkoxyalkoxy; C 2 -C 6 alkoxycarbonyl; N(CH 3 ) 2 ; or Y; R 51 is phenyl substituted with R 52 ; pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, isoxazolyl, oxazolyl, or pyrazolyl each optionally substituted with R 38 ; R 52 is 3 halogen; cyano; C 5 -C 8 alkyl; C 2 -C 8 haloalkyl; C 5 -C 8 alkoxy; ^-^ haloalkoxy; C 1 -C 8 alkylsulfonyl; C 2 -C 8 alkoxyalkyl; C 2 -C 8 alkoxy- alkoxy; C 2 -C 8 alkylthio; C 5 -C 6 cycloalkyl; C 5 -C 6 cycloalkyloxy; C -C 8 alkenyl; C 2 -C 8 halo¬ alkenyl; C 2 -C 8 alkynyl; hydroxycarbonyl; C 2 -C 8 alkoxycarbonyl; or phenoxy optionally substituted with R 29 ; R 54 is phenyl substituted with R 37 ; pyridyl or pyrimidyl each optionally substituted with R 37 ; or thienyl, furanyl, isoxazolyl, oxazolyl, or pyrazolyl each optionally substituted with R 38 ; R 57 is C ! -C 12 alkyl; C 3 -C 6 cycloalkyl; C χ -C 12 haloalkyl; C 3 -C 1 alkenyl; C 3 -C 12 haloalkenyl; C 3 -C 12 alkynyl; C 3 -C 12 haloalkynyl; phenyl, naphthalenyl or pyridyl each optionally substituted with R 41 ; or furanyl or thienyl each optionally substituted with R 42 ; R 58 is R 12 , C(=0)R 13 , C(=0)OR 13 or C (=0)NR 13 R 30 ; R 59 is phenyl optionally substituted with R 38 ; A is O, NR 25 , or a direct bond; E and V are independently 0 or S; G is -OR 51 ; -SR 51 ; -NHR 28 ; -N(CH 3 )R 28 ; -CH=CHR 28 (cis or trans); -C(=V)OR 28 ; -OC(=V)R 28 ; R 28 NR 39 C(=V)0-; -OC(=V)OR 28 ; -C (=V)NR 39 R 28 ; -(CH 2 ) m OR 59 ; -0(CH 2 ) m R 59 ; -(CH 2 ) m R 59 ; or phenyl optionally substituted with R 38 ; J is 0 or N-A-L; L is H; Ci-C j alkyl, C 3 -C 8 alkenyl; phenylmethyl optionally substituted with R 47 on the phenyl ring and R 55 on the benzylic carbon; phenyl optionally substituted with R 47 ; pyridyl optionally substituted with R 47 ; C(=0)R 22 ; C(=0)OR 22 ; or C(=0)NR 22 R 7 ; m is 1-4; n is 3-4; Q is 0, NR 11 , or a direct bond; T is phenyl optionally substituted with 1-2 halogen; CIL-C 4 alkyl; C 1 -C 4 alkoxy; trifluoromethyl; methylthio; or nitro; is 0, S, or N-Q-R 58 ; Y is -OR 28 ; -SR 28 ; -NHR 28 ; -N(CH 3 )R 28 ; -CH=CHR 28 (cis or trans); -C(=V)OR 28 ; -OC(=V)R 28 ; R 28 NR 39 C (=V) 0-; -OC(=V)OR 28 ; -C (=V)NR 39 R 28 ; -(CH 2 ) m OR 59 ; -0(CH 2 ) m R 59 ; -(CH 2 ) m R 59 ; or phenyl optionally substituted with R 38 ; and Z is phenoxy substituted with R 16 ; C 3 -C 12 alkoxyalkoxyalkoxy; benzyloxymethoxy optionally substituted on the phenyl ring with R 56 ; C 5 -C 6 cycloalkyloxy; styryl optionally substituted on the phenyl ring with R 41 ; -C(=V)0R 57 ; -OC(=V)R 57 ; -OC(=V)NR 39 R 57 ; -OC(=V)OR 57 ; -C(=V)NR 39 R 57 ; -(CH 2 ) n R 59 ; -(CH 2 ) n 0R 59 ; -0(CH 2 ) n R 59 ; or -OR 40 ; and the agriculturally suitable salts thereof; provided that: i) when W is N-Q-R 58 , Z is other than phenoxy substituted with R 16 , C 5 -Cg cycloalkyloxy, or -C(=0) (Ci-Cg alkoxy); ii) when R 2 is an optionally substituted phenyl or heterocyclic ring, only H or F can be substituted on the carbon atom(s) of the phenyl or heterocyclic ring adjacent to the carbon bearing the oxazolidinone ring; iii) when two substituents are selected from the alkyl and alkoxy groups in R 10 , R 27 , R 31 , R 36 , R 37 , R 41 , R 45 or R 46 , then at least one of said substituents contains only one carbon atom; and iv) when R 2 is alkyl substituted with optionally substituted phenyl, then the phenyl group is not attached to the alkyl carbon attached to the oxazolidinone ring.

Inventors: CAMPBELL CARLTON LANE, GROSS CHARLENE MARIE, STERNBERG JEFFREY ARTHUR, SUN KING-MO, CAMPBELL, CARLTON, LANE, GROSS, CHARLENE, MARIE, STERNBERG, JEFFREY, ARTHUR, SUN, KING-MO
Applicants: DU PONT, E.I. DU PONT DE NEMOURS AND COMPANY
Application year: 1993
Main classification: A01N43
IPC codes: A01N43, C07D263, C07D413